WO2018107466A1 - Biodegradable thrombus filter, and manufacturing method, application, and delivery device thereof - Google Patents

Biodegradable thrombus filter, and manufacturing method, application, and delivery device thereof Download PDF

Info

Publication number
WO2018107466A1
WO2018107466A1 PCT/CN2016/110385 CN2016110385W WO2018107466A1 WO 2018107466 A1 WO2018107466 A1 WO 2018107466A1 CN 2016110385 W CN2016110385 W CN 2016110385W WO 2018107466 A1 WO2018107466 A1 WO 2018107466A1
Authority
WO
WIPO (PCT)
Prior art keywords
filter
sheath
thrombus
biodegradable
porous
Prior art date
Application number
PCT/CN2016/110385
Other languages
French (fr)
Chinese (zh)
Inventor
赵清华
崔淑君
石桂欣
赵庆洪
谷涌泉
刘青
Original Assignee
北京阿迈特医疗器械有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 北京阿迈特医疗器械有限公司 filed Critical 北京阿迈特医疗器械有限公司
Priority to PCT/CN2016/110385 priority Critical patent/WO2018107466A1/en
Priority to CN201680090403.7A priority patent/CN109963527B/en
Publication of WO2018107466A1 publication Critical patent/WO2018107466A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • A61F2/0108Both ends closed, i.e. legs gathered at both ends

Definitions

  • the present invention relates to the field of medical devices, and in particular to a biodegradable thrombus filter, a preparation method and use thereof, and a delivery device for delivering the thrombus filter and a thrombus filtration system including the thrombus filter and the delivery device .
  • the thrombus filter belongs to an implantable device
  • the delivery device belongs to an interventional device.
  • VTE Venous Thromboembolism
  • DVT Deep Vein Thrombosis
  • PTE Pulmonary Thromboembolism
  • the current treatment methods are: 1, medical treatment, usually oral administration of vasoactive drugs such as dopamine, urokinase and other thrombolysis, followed by injection of heparin / oral warfarin for anticoagulation, the treatment Can only relieve symptoms, can not achieve the purpose of radical cure; 2, surgical treatment, including pulmonary thromboendothelial stripping and cardiopulmonary transplantation, the former is currently the only means to cure PTE, but the operation is difficult, high risk, China is currently at In the initial stage, the survival rate of the latter patients is less than 20% after 5 years of operation; 3.
  • vasoactive drugs such as dopamine, urokinase and other thrombolysis
  • heparin / oral warfarin for anticoagulation the treatment Can only relieve symptoms, can not achieve the purpose of radical cure
  • surgical treatment including pulmonary thromboendothelial stripping and cardiopulmonary transplantation, the former is currently the only means to cure PTE, but the operation is difficult, high risk, China is currently at In the initial stage
  • IVC Inferior vena cava
  • VCF Vena Cava Filter
  • PTE is mostly asymptomatic, so the rate of misdiagnosis and missed diagnosis is high. Once developed into a symptomatic PTE, radical cure is difficult and the patient suffers a lot. Therefore, prevention of PTE is an important way to reduce the incidence and mortality of the disease. Implantation of VCF is an important means of preventing lethal PTE.
  • VCFs used in clinical practice are prepared by laser welding and/or laser cutting of non-degradable metals.
  • laser welding and laser cutting processes are complicated and costly.
  • the product side for permanent non-degradable metal filters, even when the PTE protection is no longer needed, even the perfectly designed filter has no effect on the hemodynamics of the filter itself, and the vena cava blood flow is slow. (15-30 cm/s), any factor that interferes with its hemodynamics can cause embolism.
  • Temporary and Recyclable Non-Degradable Metal Filters There are a variety of complications during and without the evasion of the filter, including embolization caused by puncture and deployment, embolization of the instrument and blood vessel contact, etc. These embolic problems have a serious impact. Product safety and effectiveness.
  • US 2014/0188152 A1 discloses a filter that requires balloon expansion, the filter consisting of a stent and a tapered mesh portion, the end of the tapered filter is bio-
  • the degraded confinement ring after the confinement ring is degraded, the support site is adherent and endothelialized and gradually degraded and absorbed;
  • the filter disclosed in EP 2845567 A1 (2015) comprises two upper and lower recyclable hooks, which are connected by a degradable center line and a support line.
  • the recovery hook at one end is connected to the tapered filter screen, and after the support line and the center line are degraded, the filter is removed by recycling hooks at both ends.
  • VCF patents currently disclosed in China with biodegradable characteristics are 201280010783.0, 200910260085.6, 201310442071.2, 201110121164.6, 200910199830.0, 201210351175.8, 200720173001.1, 97211610.9, 201220645604.8, and 201420178084.3. These patents include fully degradable and partially degradable VCF, for The non-degradable part of the degradable VCF is mostly made of nickel-titanium or stainless steel.
  • the process for realizing the filter products of the prior art and the product structure described by the patent can be summarized into two types: the metal part is mostly prepared by laser welding or laser cutting technology, the process is complicated and the cost is high; the degradable part is mostly prepared by using a preparation process, The method is not suitable for mass production.
  • VCF has poor swellability and cannot adapt to different vascular environments, and is likely to cause serious clinical accidents such as filter displacement, vein damage or perforation.
  • biodegradable thrombus filter having a variable coefficient of expansion such that its cross-sectional size can be adaptively changed according to different blood vessel diameters, thereby being suitable for use. More extensive, filter displacement, venous damage or perforation are less likely to occur during use.
  • Another object of the present invention is to provide a method of preparing the biodegradable thrombus filter of the present invention which is simple and efficient and which can greatly reduce production costs.
  • Yet another object of the present invention is to provide a use of the biodegradable thrombus filter of the present invention.
  • the present invention provides a biodegradable thrombus filter comprising a filter body and a centerline, the filter body comprising a porous tubular stent body and two porous filter meshes at opposite ends of the porous tubular stent body,
  • the porous tubular stent body and the porous filter mesh are integrally formed from biodegradable polymer fibers deposited in a pre-designed form, the centerline being made of a biodegradable polymer; wherein one end of the centerline and one The top end of the porous filter is connected and extends through the inside of the filter through the top end of another porous filter to the outside of the filter.
  • the center line is provided with more than two card positions, and the filter can be realized through the center line and the card position. The pulling is expanded and the expansion size of the filter is adjustable.
  • the porous tubular stent body and the porous filter mesh and the centerline are integrally formed.
  • the porous tubular stent body has a circular, polygonal or irregular pattern in cross section.
  • the thrombus filter has a spherical shape, a rugby shape, a lantern shape, a centrifugal tube shape or an irregular shape, and the like.
  • the pre-designed pattern is in the form of a petal.
  • the petal form is deposited by a linear, zigzag and/or circular arc wire.
  • the porous tubular stent body and/or the biodegradable polymer fiber of the porous filter mesh are combined with the fibers at right angles, acute angles, obtuse angles, curved rounded corners or Their combination.
  • the cross-section of the porous tubular stent body and/or the porous filter web biodegradable polymer fiber is circular, polygonal or irregular.
  • the porous tubular stent body and/or the porous filter web biodegradable polymer fiber has a fixed or varying diameter to accommodate different sites of degradation planning; preferably, the biodegradable polymer fiber The diameter is from 50 nm to 1 mm, and more preferably, the biodegradable polymer fiber has a diameter of from 100 ⁇ m to 500 ⁇ m.
  • the present invention may use any biodegradable thermoplastic polymer particles, powder, crumb, or a blend of two or more biodegradable thermoplastic polymers suitable for extrusion, injection molding, and Biodegradable inorganic particles/thermoplastic polymer composites, and the like.
  • the biodegradable polymer is selected from one or more of the following: polylactic acid (PLA), L-polylactic acid (PLLA), D-polylactic acid (PDLA), polyethylene glycol-polyglycolic acid (PGA), polycaprolactone (PCL), polyethylene glycol (PEG), polyanhydride, polyhydroxyalkanoate (PHA), polydioxanone, polyiminocarbonate, polyfumaric acid a copolymer or mixture of the above materials, and a mixture of one or more of the foregoing materials with other biodegradable polymeric materials.
  • PLA polylactic acid
  • PLLA L-polylactic acid
  • PDLA D-polylactic acid
  • PGA polyethylene glycol-polyglycolic acid
  • PCL polycaprolactone
  • PEG polyethylene glycol
  • PEG polyanhydride
  • PHA polyhydroxyalkanoate
  • PDA polydioxanone
  • polyiminocarbonate polyiminocarbonate
  • the porous tubular stent body and/or porous filter mesh has fixed size pores, varying size pores or a combination of both to accommodate different site degradation planning schemes.
  • the biodegradable thrombus filter further comprises a gold wire wound thereon.
  • the gold wire can function to stabilize the structure of the thrombus filter and can function to develop and fix the thrombus filter after the thrombus filter is implanted into the body.
  • the thrombus filter is a vena cava filter.
  • the surface or part of the surface of the biodegradable thrombus filter can be treated by biological, chemical, physical or a combination thereof to inhibit cell growth or promote thrombolysis.
  • the present invention provides a method of preparing a biodegradable thrombus filter of the present invention, wherein the method is carried out using a four-axis rapid prototyping system as a manufacturing apparatus, the four-axis rapid prototyping system comprising:
  • a fourth shaft system coupled to the base, comprising a rotating rod coupled to the base below the extrusion head, wherein the rotating rod can be forward or reversed about the axis thereof Rotating; the central axis of the rotating rod is parallel to the Y axis;
  • the method includes the following steps:
  • step 2) the XYZ positioning system and the fourth axis system are controlled by the computer control system, so that the distribution system accurately extrudes the biodegradable polymer fiber according to the pre-designed deposition pattern of the biodegradable polymer fiber.
  • the tip can also be formed directly on a four-axis rapid prototyping system, with one end of the centerline connected to the top of a porous filter, and the other end of the centerline extending through the interior of the filter through the top of the other porous filter to the filter.
  • the center line is provided with more than two card positions, the tension expansion of the filter is realized by the center line and the card position, and the expansion size of the filter is adjustable, thereby obtaining a thrombus filter having a desired shape.
  • the shape of the mold in step 1) is cylindrical, spherical, rugby-shaped, lantern-shaped, centrifugal tube-shaped, or irregular; preferably, the mold is processed by 3D printing technology or traditional techniques such as CNC machining. Method preparation.
  • the mold is fixed using a clamp in step 3) or by a hollow mold placed over a rotating rod of the fourth shaft system.
  • the fixing in step 3) is to replace the rotating rod of the fourth shaft system with the mold to receive the polymer, fix it on the fourth shaft system, and enable it to be in the computer control system Under the control of the forward or reverse rotation.
  • the top end of a porous filter is directly formed on a four-axis rapid prototyping system, and the other end of the filter body precursor is stringed together with biodegradable polymer fibers to form another porous filter.
  • the method further comprises the step of 6) winding the gold wire around the thrombus filter.
  • the preparation method of the present invention is further improved on the basis of the characteristics of the thrombus filter to be prepared, based on the four-axis rapid prototyping system in the applicant's published patent applications CN 102149859 A and CN 104274867 A.
  • the extruded biodegradable polymer fibers are deposited on the mold at a set speed, pattern, and wire routing or deposited directly on the rotating rod.
  • either the feed arm or the rotating rod or both can be along the longitudinal direction (ie, the axial direction of the rotating rod). mobile.
  • the rotational speed of the rotating rod, the longitudinal movement speed of the feed arm and the rotating rod, and the outer dimensions of the mold also affect the size and density of the pore size of the porous tubular stent body and/or the porous filter, and ultimately affect the thrombus.
  • the degradation scheme of the filter is also important to affect the longitudinal movement.
  • the pattern of the porous tubular stent body and/or the porous filter mesh of the thrombus filter of the present invention is designed by a computer program; the thickness of the fiber can be controlled by a computer program, or can be controlled by a rapid prototyping system, or both can be controlled at the same time; The pores of the stent body and the porous filter are controlled by computer programs and/or mold shapes.
  • the surface area, porosity and pore size of the porous tubular scaffold and/or porous filter of the biodegradable thrombus filter depend on the structural design of the thrombus filter, including the size and geometry of the fibers, the number of fibers per unit volume, and the fibers. The structure of the structure. In most cases, these factors are more controlled by certain aspects of the manufacturing equipment, such as by rotating rods, dies or extrusion heads.
  • the mold may be of a fixed diameter or a variable diameter to adapt to the inner diameter of the vena cava of the human body.
  • the inner diameter of the vena cava is usually in the range of 18 to 32 mm, and the size of the mold is mainly based on the inner diameter of the vena cava and the needs of the thrombus filter. Designed with radial support.
  • the diameter of the extruded biodegradable polymer fiber is determined by the inner diameter of the extrusion head, the extrusion speed, the moving speed of the extrusion head along the rotating rod, and the rotational speed of the rotating rod. Sometimes, it can also be programmed. Control, such as designing repeated wire runs in certain locations to form different or identical fiber diameters at different locations, allows different sites to be degraded according to a planned protocol.
  • the biodegradable thrombus filter of the present invention can be deployed in a desired location by intervention.
  • the filter is placed in an unexpanded state, which facilitates the implementation of minimally invasive intervention, and after implantation into the blood vessel, the thrombus filter can be passed through the centerline and the card position according to the actual vessel diameter.
  • the swell size is adjusted so that the filter fits better on the inner wall of the blood vessel, so that displacement is less likely to occur.
  • the biodegradable thrombus filter has a mechanical properties and an absorbent plan that is determined by the filter material, style, and shape.
  • the invention provides the use of a biodegradable blood thrombus filter of the invention in the manufacture of a device for the prevention or treatment of venous thromboembolism, such as deep vein thrombosis and pulmonary thromboembolism.
  • the invention provides the use of a biodegradable thrombus filter of the invention for the prevention or treatment of venous thromboembolism such as deep vein thrombosis and pulmonary thromboembolism.
  • the biodegradable thrombus filter can be deployed in the IVC to capture a fatal large embolus before the embolus produced by deep vein thrombosis (DVT) reaches the lungs, preventing and reducing pulmonary thromboembolism (PTE). Or prevent and reduce PTE recurrence.
  • DVT deep vein thrombosis
  • PTE pulmonary thromboembolism
  • the present invention provides a delivery device for delivering a thrombus filter of the present invention, comprising: a vascular sheath kit comprising an outer sheath and a push sheath, the outer sheath being provided with a joint at the end The end of the push sheath is provided with a sealing cap, and the pushing sheath is matched with the outer sheath so as to be insertable into the outer sheath, wherein the conveying device further comprises a loading tube, a positioning sheath and Pulling wire, where:
  • One end of the loading tube is configured to be insertable and fixable in a joint of the outer sheath, the loading tube being configured to load a thrombus filter in an unexpanded state, and inserted and fixed at an outer sheath at one end of the loading tube
  • the connector can insert the push sheath therein and enable the push sheath to push the thrombus filter loaded therein into the outer sheath and through the outer sheath into the body;
  • the positioning sheath is wrapped outside the loading tube and is free to slide outside the device tube, the positioning sheath being provided with a scale or gear along its length, the scale or gear being configured to enable Determining a relative position of the loading tube and the positioning sheath, thereby determining an expanded size of the thrombus filter delivered to the body in vitro in combination with a pushing degree of the pushing sheath;
  • the pull wire is configured to connect the centerline of the thrombus filter during delivery of the thrombus filter and pass through the interior of the push sheath at the end of the push sheath by the closure cap, and in the thrombus filter body The above connection can be broken outside the body after reaching the desired swell size.
  • vascular sheath kit generally refers to a kit of devices that direct medical guidewires, balloons, and other instruments into the vascular lesion site during an interventional procedure.
  • the vascular sheath kit includes an outer sheath and a push sheath, and the portion according to the intended use
  • the outer sheath and the push sheath may have different gauges, for example, having different lengths and diameters.
  • the diameter may be 2F-14F and the length may be a few centimeters to eighty centimeters.
  • the push sheath is comprised of a pushable portion that is a portion of the push sheath that can be inserted into the outer sheath, the loading tube, and a positioning sheath, and the non-pushable portion After the pushable portion is fully inserted into the outer sheath, the loading tube and the positioning sheath, the non-pushable portion abuts the loading tube and/or the positioning sheath;
  • the length of the positioning sheath ⁇ the length remaining after the loading tube is inserted into the joint
  • the pushing sheath can push the length of the portion > the length of the outer sheath
  • the length remaining after the loading tube is inserted into the joint ⁇ the length difference between the push sheath pushable portion and the outer sheath ⁇ the length remaining after the loading tube is inserted into the joint + the length of the positioning sheath.
  • the loading tube and the positioning sheath are both cylindrical tubes.
  • the outer sheath, the push sheath, the loading tube and/or the positioning sheath are made of a material comprising polytetrafluoroethylene.
  • the portion of the positioning sheath having the scale or gear is transparent, translucent or hollow to facilitate viewing of the relative position of the loading tube to the positioning sheath.
  • the present invention provides a thrombus filtration system comprising the biodegradable thrombus filter of the present invention and the delivery device of the present invention.
  • the present invention also provides a method of using the delivery device or thrombus filtration system of the present invention, comprising the steps of:
  • the wire is disconnected in vitro and the delivery device is withdrawn to the outside of the body.
  • the delivery device or thrombus filtration system of the invention includes first operating in vitro to determine that the thrombus filter is fully pushed out of the outer sheath and at different expansion sizes, the end of the loading tube that is not inserted into the joint is on the scale or gear on the positioning sheath, and then the thrombus is delivered During the filter to the body, the different states and gears that have been determined are in turn determined by the state in which the thrombus filter is delivered to the body and the size of the expansion.
  • the method of using the delivery device or thrombus filtration system of the present invention comprises: first performing the following operations in vitro to determine that the thrombus filter is fully pushed out of the outer sheath and that the loading tube is not inserted into the end of the joint when in different expanded sizes
  • the scale or gear on the positioning sheath :
  • the present invention prepares a biodegradable thrombus filter having better swellability and different structures and shapes by using a bio-degradable raw material by using a four-axis rapid prototyping system.
  • the biodegradable thrombus filter of the present invention and the preparation method thereof have the following advantages:
  • the biodegradable thrombus filter of the present invention has two kinds of filters, so that the emboli in the blood vessel can be better captured or suppressed, and the PTE can be temporarily prevented, which can temporarily protect the body and disappear after completing the mission. It does not produce adverse effects on the terminal organs as shown by the traditional VCF, and the indwelling time in the body is short, avoiding the embolic problem caused by the conventional permanent filter due to the filter itself, and the temporary and recyclable filter during the insertion and recovery process. A variety of complications.
  • the biodegradable thrombus filter of the present invention can achieve planned degradation in blood vessels by selecting raw materials, structural design, and shape treatment.
  • the biodegradable thrombus filter of the present invention has a variable coefficient of expansion, and thus its cross-sectional size can be adaptively changed according to different blood vessel diameters, thereby being more applicable.
  • the filter is placed in an unexpanded state, which facilitates the implementation of minimally invasive intervention, and after implantation into the blood vessel, the thrombus filter can be passed through the centerline and the card position according to the actual vessel diameter.
  • the swell size is adjusted so that the filter fits better on the inner wall of the blood vessel, so that displacement, vein damage or perforation is less likely to occur during use.
  • the innovative traction expansion design of the invention solves the problem of release of the filter prepared by the existing biodegradable material in the internal environment, and at the same time acts to fix the filter by expansion, preventing the occurrence of displacement and reducing the product risk.
  • the preparation method of the biodegradable thrombus filter of the present invention is simpler, faster and more efficient, easier to change, and lower in cost than the preparation process of the existing filter (such as laser welding, laser cutting and braiding technology). Suitable for mass production of products.
  • the delivery system of the present invention can not only realize the minimally invasive implantation of the thrombus filter of the present invention, but also can determine the delivery state and the expansion size of the thrombus filter during implantation in vivo in vitro, and the delivery method is simple and easy to operate.
  • the conveying process is accurate and controllable.
  • the present invention also enables a single type of delivery device that can be used to deliver a variety of length gauge thrombus filters, thereby reducing inventory.
  • Example 1 is a schematic plan view showing the development of a biodegradable thrombus filter prepared in Example 1 of the present invention
  • Figure 2 is a perspective view of the biodegradable thrombus filter of Figure 1;
  • Example 3 is a perspective view showing a biodegradable thrombus filter prepared in Example 2 of the present invention.
  • FIG. 4A shows the composition and structure of the conveying device of Embodiment 3;
  • FIG. 4B illustrates several methods for pulling the wire to tie the knot;
  • FIGS. 5A to 5E are views showing a loading method of the thrombus filter of Embodiment 3; wherein, Figs. 5A to 5E sequentially show that the thrombus filter is compressed into the loading tube, and is connected to the push sheath by the pulling wire. the process of;
  • FIG. 6A to 6G are views showing sequentially a transport operation procedure of the thrombus filter of Embodiment 3; wherein, FIG. 6A shows a state diagram of a joint in which one end of the loading tube is inserted into the outer sheath; and FIG. 6B shows a push push sheath in FIG.
  • FIG. 6C shows the fixed push sheath, pull back the outer sheath, so that the loading tube is not inserted into the end of the joint to reach the positioning sheath In the 0th position, the thrombus filter is exactly exposed to the state diagram of the blood vessel;
  • Figure 6D shows the fixed outer sheath, and the push-back positioning sheath causes the loading tube to be inserted into the end of the joint to reach the positioning sheath 1 (can also be selected as needed) Different gear positions), there is a certain displacement between the loading tube and the push sheath, the thrombus filter expands a certain diameter, and is fixed by the card position on the center line;
  • FIG. 6E shows the fixed outer sheath, the push push sheath A state diagram in which the slip of the pulling wire is exposed to the outer sheath, at which time the expanded diameter of the thrombus filter has been fixed;
  • FIG. 6F shows that the sealing cap is unscrewed, pulling a pulling wire to open the nodule, releasing State diagram of the thrombus filter;
  • Figure 6G shows The state of FIG retracement push sheath, the outer sheath of the delivery device and the like;
  • Figure 7 is a view showing the contrast of the biodegradable thrombus filter of the embodiment 1 of the present invention in the inferior vena cava implantation process of the animal.
  • the four black spots in the figure are four gold wire marks, and the thrombus filter in the figure is not yet Fully expanded
  • Figure 8 is a view showing the contrast of the biodegradable thrombus filter of the embodiment 1 of the present invention in the inferior vena cava implantation process of the animal.
  • four black spots are four gold wire marks, and the thrombus filter is inflated.
  • Open state is a view showing the contrast of the biodegradable thrombus filter of the embodiment 1 of the present invention in the inferior vena cava implantation process of the animal.
  • four black spots are four gold wire marks, and the thrombus filter is inflated.
  • Figure 9 is a photographic diagram of the biodegradable thrombus filter of Example 1 of the present invention after 2 weeks of implantation in an animal.
  • the four black spots in the figure are four gold wire marks, and the thrombus filter is inflated. In the open state, no migration occurred.
  • Biodegradable thrombus filter for the inferior vena cava using polycaprolactone as a raw material, the specific processing steps are as follows:
  • step 2) the XYZ positioning system and the fourth axis system are controlled by the computer control system, so that the distribution system accurately extrudes the polymer fiber according to the pre-designed deposition pattern of the biodegradable polymer fiber, and deposits it in the first a specific position of the mold that can be rotated on the four axes to prepare a porous filter body precursor;
  • step 4) (the planar development view is shown in Fig. 1) is taken out from the mold, and the other end of the filter body precursor is stringed with polycaprolactone fibers to form another porous The top end of the filter 104.
  • centerline 102 One end of the centerline 102 is coupled to the top end of a porous filter screen 104, and the other end of the centerline 102 extends through the interior of the filter 100 through the top end of another porous filter screen 104 to the exterior of the filter 100, wherein the centerline 102
  • Three latching positions 105 are provided thereon, the pulling expansion of the filter 100 is achieved by the center line 102 and the latching position 105, and the expansion size of the filter 100 is adjustable, thereby obtaining a thrombus filter 100 having a desired shape (see a perspective view thereof). figure 2).
  • the four portions shown by the arrows in Fig. 2 are respectively ligated and fixed by the gold wire 110, and the length of the exposed gold wire 110 is determined according to the thickness of the vein wall.
  • the gold wire 110 can function to stabilize the thrombus filter 100 and can function to develop and fix a thrombus filter after being implanted in the body.
  • the thrombus filter 100 includes a filter body 101 and a centerline 102, the filter body 101 including a porous tubular stent body 103 and two porous filter screens 104 at both ends of the porous tubular stent body 103, More than two card positions are arranged on the center line 102 105.
  • a biodegradable thrombus filter using polylactic acid as a raw material the specific processing steps are as follows:
  • the computer designed biodegradable polymer fiber is deposited into a petal form by a zigzag wire; wherein the tops of the two porous filters are directly formed on the four-axis rapid prototyping system;
  • step 2) the XYZ positioning system and the fourth axis system are controlled by the computer control system, so that the distribution system accurately extrudes the polymer fiber according to the pre-designed deposition pattern of the biodegradable polymer fiber, and deposits it in the first a specific position of the mold that can be rotated on the four axes to prepare a porous filter body precursor;
  • the filter body precursor prepared in the step 4) after cooling is taken out from the mold.
  • One end of the centerline 202 is coupled to the top end of a porous filter screen 204, and the other end of the centerline 202 extends through the interior of the filter 200 through the top end of another porous filter screen 204 to the exterior of the filter 200, wherein the centerline 202 A card slot 205 is disposed thereon, and the tension expansion of the filter 200 is achieved by the center line 202 and the card position 205 and the expansion size of the filter 200 is adjusted, thereby obtaining a thrombus filter 200 having a desired shape (the perspective view thereof is shown in FIG. 3).
  • the thrombus filter 200 includes a filter body 201 and a centerline 202, the filter body 201 including a porous tubular stent body 203 and two porous filter screens 204 at opposite ends of the porous tubular stent body 203, Two or more card positions 205 are disposed on the center line 202.
  • Biodegradable thrombus filter delivery device and method of use thereof are:
  • the delivery device used consisted of a 10F vascular sheath kit (available from COOK Medical) (including outer sheath 1 and push sheath 2), a 10F loading tube 3, a positioning sheath 4, and a 0.3 mm diameter nylon pull wire 5 (see Figure 4A). .
  • Vascular sheath material sheath 6: polytetrafluoroethylene, barium sulfate; hemostatic valve 7: high density polyethylene, silica gel; side arm connecting tube 8: polyvinyl chloride; joint 9: polycarbonate.
  • Loading tube 3 material polytetrafluoroethylene.
  • Positioning sheath 4 material polytetrafluoroethylene.
  • the vena cava angiography is first performed, and the inner diameter of the target site is measured to determine the thrombus filter size.
  • the vena cava angiography is first performed, and the inner diameter of the target site is measured to determine the thrombus filter size.
  • it is first operated in vitro to determine the scale or position of the end of the loading tube that is not inserted into the sheath when the thrombus filter is fully pushed out of the sheath and at different expansion sizes. .
  • FIGS. 5A to 5E show schematic views of the loading method of the thrombus filter.
  • the specific operation is to compress the thrombus filter 11 into the loading tube 3 to expose the tail of the thrombus filter center line 12.
  • the pulling wire 5 is fixed in the trailing end hole 13 of the thrombus filter center line 12 by means of activating the knot (as shown in Fig. 4B).
  • the drawing wire 5 is inserted into and out of the pushing sheath 2, and the pulling wire 5 is tightened until the tip end of the pushing sheath is attached to the tail of the thrombus filter 11, and the sealing cap 14 is screwed to fix the pulling wire 5, which At this time, the push sheath 2 and the loading tube 3 are integrally connected by the pulling wire 5 and the thrombus filter 11.
  • FIG. 6A to 6G sequentially show the transporting operation of the thrombus filter: one end of the loading tube 3 is inserted into the outer sheath 1 to the end of the luer 9 (see Fig. 6A). The positioning sheath 4 is moved so that the D position reaches the end of the loading tube 3 that is not inserted into the joint, and the push sheath 2 is advanced until it is caught by the positioning sheath 4, at which time 1/3 of the thrombus filter 11 is exposed in the blood vessel (see Fig. 6B). .
  • the push sheath 2 is fixed, and the outer sheath 1 is pulled back so that the end of the loading tube 3 not inserted into the joint reaches the 0 position of the positioning sheath 4, at which time the thrombus filter 11 is completely exposed to the blood vessel (see Fig. 6C).
  • the outer sheath 1 is fixed, and the positioning sheath 4 is pushed back so that the end of the loading tube 3 not inserted into the joint reaches the first gear such as the positioning sheath 4 (the different gear positions can be selected as needed), and the card position on the center line 12 is pulled.
  • the tail end of the thrombus filter 11 is pulled out of the thrombus filter 11, and the thrombus filter 11 is thereby expanded to a certain diameter (see Fig. 6D).
  • the outer sheath 1 is fixed, and the push sheath 2 is advanced to expose the slip of the pull wire 5 to the outer sheath 1 (see Fig. 6E).
  • the sealing cap 14 is unscrewed, one of the pulling wires 5 is pulled, the nodule is opened, the pulling wire 5 is withdrawn, and the thrombus filter 11 is released (see Fig. 6F).
  • the delivery device such as the push sheath 2 and the outer sheath 1 is withdrawn (see Fig. 6G).
  • the experiment selected a healthy adult Chinese miniature pig model (purchased from the Experimental Animal Center of China Agricultural University), established a venous access through the common femoral vein, and then underwent inferior vena cava angiography to determine blood.
  • the plug filter specification and the implant site are used to implant the thrombus filter into the designated site according to the method of use of the delivery device.
  • the thrombus filter In the process of implanting the body, the thrombus filter is first placed in an unexpanded state, and after reaching the position to be placed, the thrombus filter is gradually expanded by pulling the center line, and different card positions on the center line are utilized. Fix the centerline to adjust the shape and size of the thrombus filter so that the thrombus filter fits more closely with the vessel wall.
  • the thrombus filter was used to evaluate the lumen patency of the thrombus implant site after embolization. Two weeks later, the experimental pigs underwent an inferior vena cava angiography to see if the thrombus filter was still in its original position and remained in an expanded state.
  • FIG. 7 is a contrast diagram of the biodegradable thrombus filter of Example 1 implanted in the inferior vena cava of an animal.
  • the four black spots in the figure are four gold wire marks, and the thrombus filter is not yet in the figure.
  • Figure 8 shows a contrast image of the thrombus filter in an expanded state. After the thrombus filter was implanted in the animal for 2 weeks, the angiogram is shown in Fig. 9. It can be seen that the thrombus filter is still in an expanded state, and no migration occurs, and the blood vessel is not damaged or perforated.

Abstract

A biodegradable thrombus filter (100, 200, 11), a manufacturing method and application thereof, and a delivery device for delivering the thrombus filter (100, 200, 11), and a thrombus filter system comprising the thrombus filter (100, 200, 11) and the delivery device. The biodegradable thrombus filter (100, 200, 11) comprises a filter body (101, 201) and a center line (102, 202, 12). The filter body (101, 201) comprises a porous tubular frame (103, 203) and two porous filter mesh (104, 204) positioned at two ends of the porous tubular frame body (103, 203). The porous tubular frame (103, 203) and porous filter mesh (104, 204) are seamlessly formed via deposition of a biodegradable polymer fiber according to a pre-designed model. The center line (102, 202, 12) is manufactured using a biodegradable polymer. The center line (102, 202, 12) has one end connected to a top portion of the porous filter mesh (104, 204), passes through an internal portion of the filter (100, 200, 11) and the top portion of another porous filter mesh (104, 204), and extends outside the filter (100, 200, 11). The center line (102, 202, 12) is provided with two or more locking positions (105, 205). The center line (102, 202, 12) and the locking positions (105, 205) realize expansion of the filter (100, 200, 11) through a pulling action and allow adjustment to the size of filter expansion. The thrombus filter (100, 200, 11) has an adjustable expansion coefficient, so is less likely to be displaced, or to damage or perforate a vein during use.

Description

生物可降解血栓过滤器及其制备方法、用途和输送装置Biodegradable thrombus filter, preparation method thereof, use and conveying device 技术领域Technical field
本发明属于医疗器械领域,具体涉及一种生物可降解血栓过滤器及其制备方法和用途,以及用于输送所述血栓过滤器的输送装置和包含所述血栓过滤器和输送装置的血栓过滤系统。其中,血栓过滤器属于植入类器械,输送装置属于介入类器械。The present invention relates to the field of medical devices, and in particular to a biodegradable thrombus filter, a preparation method and use thereof, and a delivery device for delivering the thrombus filter and a thrombus filtration system including the thrombus filter and the delivery device . Among them, the thrombus filter belongs to an implantable device, and the delivery device belongs to an interventional device.
背景技术Background technique
静脉血栓栓塞症(Venous Thromboembolism,VTE)包括深静脉血栓形成(Deep Vein Thrombosis,DVT)和肺血栓栓塞(Pulmonary Thromboembolism,PTE)。Venous Thromboembolism (VTE) includes Deep Vein Thrombosis (DVT) and Pulmonary Thromboembolism (PTE).
确诊VTE后,根据病患特点,目前的治疗手段有:1、内科治疗,通常口服多巴胺等血管活性药物,尿激酶等溶栓,之后注射肝素/口服华法林等进行抗凝,该治疗手段只能缓解症状,达不到根治的目的;2、手术治疗,包括肺动脉血栓内膜剥脱术和心肺移植术,前者是目前唯一可以根治PTE的手段,但手术难度大,风险高,我国目前处于起步阶段,而后者术后5年患者存活率不到20%;3、碎解和抽吸血栓式的介入治疗,该方法效果不是很好,打碎的小栓子后期易造成再次栓塞;4、下腔静脉(inferior vena cava,IVC)干扰,包括IVC结扎和植入腔静脉滤器(Vena Cava Filter,VCF),两者都可以预防PTE复发和致死性PTE,但IVC结扎仍有20%的患者可以通过侧枝循环再次发生PTE,IVC被阻断后,血液回流受限,会出现相对严重的并发症,而且术后死亡率也较高。VCF是一种类似于滤网的器械,被部署在血管中,物理拦截漂浮的血栓。After the diagnosis of VTE, according to the characteristics of patients, the current treatment methods are: 1, medical treatment, usually oral administration of vasoactive drugs such as dopamine, urokinase and other thrombolysis, followed by injection of heparin / oral warfarin for anticoagulation, the treatment Can only relieve symptoms, can not achieve the purpose of radical cure; 2, surgical treatment, including pulmonary thromboendothelial stripping and cardiopulmonary transplantation, the former is currently the only means to cure PTE, but the operation is difficult, high risk, China is currently at In the initial stage, the survival rate of the latter patients is less than 20% after 5 years of operation; 3. The interventional treatment of disintegration and aspiration thrombus is not very effective, and the broken small embolism is easy to cause re-embolization; 4 Inferior vena cava (IVC) interference, including IVC ligation and implantation of Vena Cava Filter (VCF), both can prevent PTE recurrence and lethal PTE, but IVC ligation is still 20% Patients can re-occur PTE through the collateral circulation. After IVC is blocked, blood reflux is limited, relatively serious complications occur, and postoperative mortality is also high. The VCF is a filter-like device that is deployed in blood vessels to physically intercept floating blood clots.
PTE多数为无症状型,因此误诊率、漏诊率很高。一旦发展成症状型PTE,根治很困难,病人承受的痛苦非常大。因此,预防PTE成为降低该病发病率、死亡率的重要途径。而植入VCF成为预防致死性PTE的重要手段。PTE is mostly asymptomatic, so the rate of misdiagnosis and missed diagnosis is high. Once developed into a symptomatic PTE, radical cure is difficult and the patient suffers a lot. Therefore, prevention of PTE is an important way to reduce the incidence and mortality of the disease. Implantation of VCF is an important means of preventing lethal PTE.
目前临床上使用的VCF都采用激光焊接和/或激光切割不可降解的金属制备,然而,激光焊接和激光切割工艺复杂、成本高。产品方面,对于永久性不可降解金属滤器,当PTE保护不再需要时,即使是设计很完美的滤器仍无法规避滤器本身对血流动力学的影响,而腔静脉血流速度较慢 (15-30cm/s),任何干扰其血流动力学的因素均可以引起栓塞。临时性和可回收不可降解金属滤器无法规避滤器放置过程中和回收过程中产生的多种并发症,包括穿刺和展开引发的栓塞、器械和血管接触部分的栓塞形成等,这些栓塞问题严重影响了产品的安全性和有效性。Currently, VCFs used in clinical practice are prepared by laser welding and/or laser cutting of non-degradable metals. However, laser welding and laser cutting processes are complicated and costly. On the product side, for permanent non-degradable metal filters, even when the PTE protection is no longer needed, even the perfectly designed filter has no effect on the hemodynamics of the filter itself, and the vena cava blood flow is slow. (15-30 cm/s), any factor that interferes with its hemodynamics can cause embolism. Temporary and Recyclable Non-Degradable Metal Filters There are a variety of complications during and without the evasion of the filter, including embolization caused by puncture and deployment, embolization of the instrument and blood vessel contact, etc. These embolic problems have a serious impact. Product safety and effectiveness.
具有生物可降解特征的新型VCF相关专利已经在国际范围内陆续公开,比如US 6267776 B1(2001年,Paul T.O’Connell等人)公开了一种滤器,该滤器支撑部位是平行的6条金属丝,端部或中间部位被约束环束缚在一起形成锥形或双锥形结构,约束环采用生物可降解材料,降解后,滤器可转换成支架发挥作用;US 2009/0105747 A1(2009年,Bard)公开的滤器包含一个支架部分和支架一端/两端的滤网部分,滤网部分采用生物可降解缝线编织而成;US 2010/0016881 A1(2010年,Cook)公开了一种生物可降解滤器,该滤器通过将一端约束的4条可降解纤维自由端嵌在几排平行的直径渐大zig-zag结构环上形成锥形的结构;US 8236039 B2(2012年,Abbott)公开了一种漏斗形滤器,该滤器膨大部位具有生物可降解的壁挂与血管壁贴合,壁挂的作用是将滤器与血管内表面分离,从而抑制滤器的内皮化,否则滤器需要手术进行回收;US 2014/0188152 A1(2014年,Cook)公开了一种需要球囊扩张的滤器,该滤器由支架和锥形滤网部分组成,锥形滤网端部是生物可降解的约束环,约束环降解后支撑部位贴壁内皮化并逐渐降解吸收;EP 2845567 A1(2015年)公开的滤器包含上下两个可回收钩,通过可降解的中心线和支撑线连成一体,一端回收钩与锥形滤网相连,支撑线和中心线降解后,通过两端回收钩分别将滤器去除。Novel VCF-related patents with biodegradable features have been published internationally, such as US 6,267,776 B1 (2001, Paul T. O'Connell et al.), which discloses a filter having six parallel support portions. The wire, the end or the intermediate part is bound together by a confinement ring to form a conical or biconical structure, the confinement ring is made of a biodegradable material, and after the degradation, the filter can be converted into a stent to function; US 2009/0105747 A1 (2009) , Bard) discloses a filter comprising a stent portion and a filter portion at one end/both of the stent, the screen portion being woven with biodegradable suture; US 2010/0016881 A1 (2010, Cook) discloses a bio-available a degrading filter that is formed by concealing the free ends of four degradable fibers constrained at one end into rows of parallel diameter-increasing zig-zag structural rings; US 8236039 B2 (Abbott, 2012) discloses a funnel-shaped filter having a biodegradable wall and a blood vessel wall attached to the enlarged portion of the filter, and the wall hanging function is to separate the filter from the inner surface of the blood vessel, thereby suppressing the endothelialization of the filter. The filter requires surgery for recovery; US 2014/0188152 A1 (2014, Cook) discloses a filter that requires balloon expansion, the filter consisting of a stent and a tapered mesh portion, the end of the tapered filter is bio- The degraded confinement ring, after the confinement ring is degraded, the support site is adherent and endothelialized and gradually degraded and absorbed; the filter disclosed in EP 2845567 A1 (2015) comprises two upper and lower recyclable hooks, which are connected by a degradable center line and a support line. The recovery hook at one end is connected to the tapered filter screen, and after the support line and the center line are degraded, the filter is removed by recycling hooks at both ends.
中国目前公开的具有生物可降解特征的相关VCF专利有201280010783.0、200910260085.6、201310442071.2、201110121164.6、200910199830.0、201210351175.8、200720173001.1、97211610.9、201220645604.8、以及201420178084.3,这些专利包括完全可降解和部分可降解的VCF,对于部分可降解的VCF非降解部分多采用镍钛、不锈钢等材料。The relevant VCF patents currently disclosed in China with biodegradable characteristics are 201280010783.0, 200910260085.6, 201310442071.2, 201110121164.6, 200910199830.0, 201210351175.8, 200720173001.1, 97211610.9, 201220645604.8, and 201420178084.3. These patents include fully degradable and partially degradable VCF, for The non-degradable part of the degradable VCF is mostly made of nickel-titanium or stainless steel.
实现现有技术的滤器商品及专利所述的产品结构的工艺可以归纳为两种:金属部分多采用激光焊接或激光切割技术制备,该工艺复杂、成本高;可降解部分多采用编制工艺,该种方法不适于大批量生产。The process for realizing the filter products of the prior art and the product structure described by the patent can be summarized into two types: the metal part is mostly prepared by laser welding or laser cutting technology, the process is complicated and the cost is high; the degradable part is mostly prepared by using a preparation process, The method is not suitable for mass production.
此外,现有的VCF可膨胀性能较差,不能适应不同的血管环境,易造成滤器移位、静脉损伤或穿孔等严重临床事故。 In addition, the existing VCF has poor swellability and cannot adapt to different vascular environments, and is likely to cause serious clinical accidents such as filter displacement, vein damage or perforation.
发明内容Summary of the invention
因此,本发明的一个目的是提供一种生物可降解血栓过滤器,所述血栓过滤器具有变化的可膨胀系数,因而其横截面尺寸可以根据不同的血管直径进行适应性地改变,从而适用范围更广,在使用过程中不易发生滤器移位、静脉损伤或穿孔。Accordingly, it is an object of the present invention to provide a biodegradable thrombus filter having a variable coefficient of expansion such that its cross-sectional size can be adaptively changed according to different blood vessel diameters, thereby being suitable for use. More extensive, filter displacement, venous damage or perforation are less likely to occur during use.
本发明的另一个目的是提供一种制备本发明的生物可降解血栓过滤器的方法,该方法简易、高效,可以大大节约生产成本。Another object of the present invention is to provide a method of preparing the biodegradable thrombus filter of the present invention which is simple and efficient and which can greatly reduce production costs.
本发明的又一个目的是提供一种本发明的生物可降解血栓过滤器的用途。Yet another object of the present invention is to provide a use of the biodegradable thrombus filter of the present invention.
本发明的再一个目的是提供一种输送装置,该输送装置与本发明的血栓过滤器配套使用,用于输送所述血栓过滤器。It is still another object of the present invention to provide a delivery device for use with the thrombus filter of the present invention for delivering the thrombus filter.
本发明的又一个目的是提供一种血栓过滤系统。It is still another object of the present invention to provide a thrombus filtration system.
本发明的目的是通过以下技术方案来实现的。The object of the present invention is achieved by the following technical solutions.
一方面,本发明提供一种生物可降解血栓过滤器,其包括滤器主体和中心线,所述滤器主体包括多孔管状支架体和位于所述多孔管状支架体两端的两个多孔过滤网,所述多孔管状支架体和多孔过滤网是由生物可降解聚合物纤维按照预先设计的式样沉积而一体成型的,所述中心线由生物可降解聚合物制成;其中,所述中心线的一端与一个多孔过滤网的顶端相连,并经由过滤器内部延伸通过另一个多孔过滤网的顶端至过滤器的外部,所述中心线上设置有两个以上卡位,通过中心线及卡位能够实现过滤器的牵拉膨胀并且过滤器的膨开尺寸可调。In one aspect, the present invention provides a biodegradable thrombus filter comprising a filter body and a centerline, the filter body comprising a porous tubular stent body and two porous filter meshes at opposite ends of the porous tubular stent body, The porous tubular stent body and the porous filter mesh are integrally formed from biodegradable polymer fibers deposited in a pre-designed form, the centerline being made of a biodegradable polymer; wherein one end of the centerline and one The top end of the porous filter is connected and extends through the inside of the filter through the top end of another porous filter to the outside of the filter. The center line is provided with more than two card positions, and the filter can be realized through the center line and the card position. The pulling is expanded and the expansion size of the filter is adjustable.
优选地,所述多孔管状支架体和多孔过滤网以及中心线是一体成型的。Preferably, the porous tubular stent body and the porous filter mesh and the centerline are integrally formed.
优选地,所述多孔管状支架体的横截面为圆形、多边形或不规则图形。Preferably, the porous tubular stent body has a circular, polygonal or irregular pattern in cross section.
优选地,所述血栓过滤器的外形为圆球形、橄榄球形、灯笼形、离心管形或不规则形状等。Preferably, the thrombus filter has a spherical shape, a rugby shape, a lantern shape, a centrifugal tube shape or an irregular shape, and the like.
优选地,所述预先设计的式样为花瓣形式样。Preferably, the pre-designed pattern is in the form of a petal.
优选地,所述花瓣形式样由直线形、Z字形和/或圆弧形走丝方式沉积出来。Preferably, the petal form is deposited by a linear, zigzag and/or circular arc wire.
优选地,所述多孔管状支架体和/或多孔过滤网的生物可降解聚合物纤维与纤维之间呈直角结合、锐角结合、钝角结合、有弧度的圆角结合或者 它们的组合。Preferably, the porous tubular stent body and/or the biodegradable polymer fiber of the porous filter mesh are combined with the fibers at right angles, acute angles, obtuse angles, curved rounded corners or Their combination.
优选地,所述多孔管状支架体和/或多孔过滤网的生物可降解聚合物纤维的横截面为圆形、多边形或不规则形状。Preferably, the cross-section of the porous tubular stent body and/or the porous filter web biodegradable polymer fiber is circular, polygonal or irregular.
优选地,所述多孔管状支架体和/或多孔过滤网的生物可降解聚合物纤维具有固定的或变化的直径以适应不同部位的降解计划方案;优选地,所述生物可降解聚合物纤维的直径为50纳米至1毫米,更优选地,所述生物可降解聚合物纤维的直径为100微米至500微米。Preferably, the porous tubular stent body and/or the porous filter web biodegradable polymer fiber has a fixed or varying diameter to accommodate different sites of degradation planning; preferably, the biodegradable polymer fiber The diameter is from 50 nm to 1 mm, and more preferably, the biodegradable polymer fiber has a diameter of from 100 μm to 500 μm.
本发明可以使用适用于挤出、注塑成型的任何一种生物可降解的热塑性聚合物颗粒、粉末、碎屑,两种或两种以上生物可降解的热塑性聚合物混合成的共混物,以及生物可降解无机粒子/热塑性聚合物复合材料等。The present invention may use any biodegradable thermoplastic polymer particles, powder, crumb, or a blend of two or more biodegradable thermoplastic polymers suitable for extrusion, injection molding, and Biodegradable inorganic particles/thermoplastic polymer composites, and the like.
优选地,所述生物可降解聚合物选自以下的一种或多种:聚乳酸(PLA)、左旋聚乳酸(PLLA)、右旋聚乳酸(PDLA)、聚乙二醇-聚羟基乙酸(PGA)、聚己酸内酯(PCL)、聚乙二醇(PEG)、聚酸酐、聚羟基脂肪酸酯(PHA)、聚对二氧环己酮、聚亚氨基碳酸酯、聚富马酸、上述材料的共聚物或混合物,以及上述材料中的一种或多种与生物可降解的其它高分子材料的混合物。Preferably, the biodegradable polymer is selected from one or more of the following: polylactic acid (PLA), L-polylactic acid (PLLA), D-polylactic acid (PDLA), polyethylene glycol-polyglycolic acid ( PGA), polycaprolactone (PCL), polyethylene glycol (PEG), polyanhydride, polyhydroxyalkanoate (PHA), polydioxanone, polyiminocarbonate, polyfumaric acid a copolymer or mixture of the above materials, and a mixture of one or more of the foregoing materials with other biodegradable polymeric materials.
优选地,所述多孔管状支架体和/或多孔过滤网具有固定尺寸的孔隙、变化尺寸的孔隙或两者的结合,以适应不同部位的降解计划方案。Preferably, the porous tubular stent body and/or porous filter mesh has fixed size pores, varying size pores or a combination of both to accommodate different site degradation planning schemes.
优选地,所述生物可降解血栓过滤器还包括缠绕在其上的金丝。所述金丝可以起到稳定血栓过滤器结构的作用,并且在将血栓过滤器植入体内后可以起到显影以及固定血栓过滤器的作用。Preferably, the biodegradable thrombus filter further comprises a gold wire wound thereon. The gold wire can function to stabilize the structure of the thrombus filter and can function to develop and fix the thrombus filter after the thrombus filter is implanted into the body.
优选地,所述血栓过滤器为腔静脉滤器。Preferably, the thrombus filter is a vena cava filter.
优选地,可以对生物可降解血栓过滤器的表面或部分表面通过生物、化学、物理或者它们结合使用的方法进行处理来抑制细胞生长或促进血栓溶解。Preferably, the surface or part of the surface of the biodegradable thrombus filter can be treated by biological, chemical, physical or a combination thereof to inhibit cell growth or promote thrombolysis.
另一方面,本发明提供一种制备本发明所述的生物可降解血栓过滤器的方法,其中,所述方法使用四轴快速成型系统作为制造设备来进行,所述四轴快速成型系统包括:In another aspect, the present invention provides a method of preparing a biodegradable thrombus filter of the present invention, wherein the method is carried out using a four-axis rapid prototyping system as a manufacturing apparatus, the four-axis rapid prototyping system comprising:
(i)基座;(i) a pedestal;
(ii)连接于所述基座的三轴X-Y-Z定位系统,其中所述X-Y-Z定位系统分别限定X、Y、Z方向;(ii) a three-axis X-Y-Z positioning system coupled to the base, wherein the X-Y-Z positioning system defines X, Y, and Z directions, respectively;
(iii)安装在所述X-Y-Z定位系统上,并通过所述X-Y-Z定位系统移 动的分配系统,所述分配系统含有一个挤出头;(iii) mounted on the X-Y-Z positioning system and moved by the X-Y-Z positioning system a dispensing system comprising an extrusion head;
(iv)连接于所述基座的第四轴系统,其包含在所述挤出头下方连接于所述基座的旋转杆,其中,所述旋转杆可以围绕其中轴作正向或反向转动;所述旋转杆的中轴平行于Y轴;以及(iv) a fourth shaft system coupled to the base, comprising a rotating rod coupled to the base below the extrusion head, wherein the rotating rod can be forward or reversed about the axis thereof Rotating; the central axis of the rotating rod is parallel to the Y axis;
(v)计算机控制系统,其可以根据设定的程序精确地控制X-Y-Z定位系统从而精确地控制分配系统的挤出头在X、Y、Z方向上的运动,并且精确地控制第四轴系统的旋转杆围绕其中轴的转动;(v) a computer control system that can accurately control the XYZ positioning system according to a set program to accurately control the movement of the extrusion head of the dispensing system in the X, Y, Z directions, and precisely control the fourth axis system Rotation of the rotating rod about its axis;
所述方法包括以下步骤:The method includes the following steps:
1)根据所要制备的过滤器的外形、尺寸来制备实心或空心的模具;1) preparing a solid or hollow mold according to the shape and size of the filter to be prepared;
2)采用计算机设计生物可降解聚合物纤维的沉积式样的程序;2) a program for designing a deposition pattern of biodegradable polymer fibers using a computer;
3)将所述模具固定到所述四轴快速成型系统的第四轴系统的旋转杆的位置处,使其能够在计算机控制系统的控制下随第四轴旋转杆作正向或反向转动;并将生物可降解聚合物加入四轴快速成型系统的分配系统内;3) fixing the mold to the position of the rotating rod of the fourth shaft system of the four-axis rapid prototyping system, so that it can rotate in the forward or reverse direction with the fourth shaft rotating rod under the control of the computer control system And incorporating the biodegradable polymer into the dispensing system of the four-axis rapid prototyping system;
4)按照步骤2)设计的程序通过计算机控制系统控制X-Y-Z定位系统和第四轴系统,使分配系统精确地按照预先设计的生物可降解聚合物纤维的沉积式样挤出生物可降解聚合物纤维,沉积在第四轴上可以旋转的模具的特定位置或者直接沉积在旋转杆上,从而制备出具有特定尺寸和结构的滤器主体前体;4) According to the procedure designed in step 2), the XYZ positioning system and the fourth axis system are controlled by the computer control system, so that the distribution system accurately extrudes the biodegradable polymer fiber according to the pre-designed deposition pattern of the biodegradable polymer fiber. Depositing a specific position of the mold that can be rotated on the fourth shaft or directly deposited on the rotating rod to prepare a filter body precursor having a specific size and structure;
5)将步骤4)制备的滤器主体前体从模具上取下来,并将其两端分别用生物可降解聚合物纤维串起来形成多孔过滤网的顶端,或者其中一个或两个多孔过滤网的顶端也可以是在四轴快速成型系统上直接成型的,将中心线的一端连接到一个多孔过滤网的顶端,中心线的另一端经过滤器内部延伸通过另一个多孔过滤网的顶端至过滤器的外部,所述中心线上设置有两个以上卡位,通过中心线和卡位实现过滤器的牵拉膨胀并且过滤器的膨开尺寸可调,从而得到具有所需外形的血栓过滤器。5) removing the filter body precursor prepared in the step 4) from the mold, and stringing the two ends thereof with biodegradable polymer fibers to form the top of the porous filter, or one or two of the porous filters. The tip can also be formed directly on a four-axis rapid prototyping system, with one end of the centerline connected to the top of a porous filter, and the other end of the centerline extending through the interior of the filter through the top of the other porous filter to the filter. Externally, the center line is provided with more than two card positions, the tension expansion of the filter is realized by the center line and the card position, and the expansion size of the filter is adjustable, thereby obtaining a thrombus filter having a desired shape.
优选地,步骤1)中所述模具的外形为圆筒形、圆球形、橄榄球形、灯笼形、离心管形、或不规则形状;优选所述模具采用3D打印技术或者传统技术如数控机床加工方法制备。Preferably, the shape of the mold in step 1) is cylindrical, spherical, rugby-shaped, lantern-shaped, centrifugal tube-shaped, or irregular; preferably, the mold is processed by 3D printing technology or traditional techniques such as CNC machining. Method preparation.
优选地,步骤3)中使用夹具对模具进行固定,或者通过将空心的模具套在第四轴系统的旋转杆上进行固定。Preferably, the mold is fixed using a clamp in step 3) or by a hollow mold placed over a rotating rod of the fourth shaft system.
优选地,步骤3)中所述固定是用所述模具替代第四轴系统的旋转杆来接收聚合物,将其固定在第四轴系统上,并使其能够在计算机控制系统 的控制下作正向或反向转动。Preferably, the fixing in step 3) is to replace the rotating rod of the fourth shaft system with the mold to receive the polymer, fix it on the fourth shaft system, and enable it to be in the computer control system Under the control of the forward or reverse rotation.
优选地,在步骤5)中,一个多孔过滤网的顶端是在四轴快速成型系统上直接成型的,用生物可降解聚合物纤维将滤器主体前体的另一端串起来形成另一个多孔过滤网的顶端。Preferably, in step 5), the top end of a porous filter is directly formed on a four-axis rapid prototyping system, and the other end of the filter body precursor is stringed together with biodegradable polymer fibers to form another porous filter. The top of the.
优选地,所述方法还包括步骤6)将金丝缠绕在血栓过滤器上。Preferably, the method further comprises the step of 6) winding the gold wire around the thrombus filter.
本发明的制备方法在申请人已经公开的专利申请CN 102149859 A和CN 104274867 A中的四轴快速成型系统的基础上,根据要制备的血栓过滤器的特点做了进一步改进。挤出的生物可降解聚合物纤维按照设定的速度、式样及走丝方式沉积在模具上或直接沉积在旋转杆上。为了更好地控制多孔管状支架体和/或多孔过滤网的孔隙率、孔的大小和结构,不管是送料臂还是旋转杆或是两者都可以沿着纵向(即旋转杆的轴向方向)移动。除了纵向的移动外,旋转杆的转速、送料臂和旋转杆的纵向移动速度以及模具的外形尺寸也同样影响着多孔管状支架体和/或多孔过滤网的孔径的大小、密度,并最终影响血栓过滤器的降解方案。The preparation method of the present invention is further improved on the basis of the characteristics of the thrombus filter to be prepared, based on the four-axis rapid prototyping system in the applicant's published patent applications CN 102149859 A and CN 104274867 A. The extruded biodegradable polymer fibers are deposited on the mold at a set speed, pattern, and wire routing or deposited directly on the rotating rod. In order to better control the porosity, pore size and structure of the porous tubular stent body and/or the porous filter, either the feed arm or the rotating rod or both can be along the longitudinal direction (ie, the axial direction of the rotating rod). mobile. In addition to the longitudinal movement, the rotational speed of the rotating rod, the longitudinal movement speed of the feed arm and the rotating rod, and the outer dimensions of the mold also affect the size and density of the pore size of the porous tubular stent body and/or the porous filter, and ultimately affect the thrombus. The degradation scheme of the filter.
本发明的血栓过滤器的多孔管状支架体和/或多孔过滤网的式样由计算机程序设计;纤维的粗细可以通过计算机程序设计,也可以通过快速成型系统控制,还可以两者同时控制;多孔管状支架体和多孔过滤网的孔隙由计算机程序和/或模具形状控制。The pattern of the porous tubular stent body and/or the porous filter mesh of the thrombus filter of the present invention is designed by a computer program; the thickness of the fiber can be controlled by a computer program, or can be controlled by a rapid prototyping system, or both can be controlled at the same time; The pores of the stent body and the porous filter are controlled by computer programs and/or mold shapes.
生物可降解血栓过滤器的多孔管状支架体和/或多孔过滤网的表面积、孔隙率和孔径大小取决于血栓过滤器的结构设计,包括纤维的尺寸和几何形状、单位体积内的纤维数和纤维的结构式样。绝大多数情况下,这些因素更多的是由制造设备的某些特定方面来控制的,如通过旋转杆、模具或者挤出头来控制。The surface area, porosity and pore size of the porous tubular scaffold and/or porous filter of the biodegradable thrombus filter depend on the structural design of the thrombus filter, including the size and geometry of the fibers, the number of fibers per unit volume, and the fibers. The structure of the structure. In most cases, these factors are more controlled by certain aspects of the manufacturing equipment, such as by rotating rods, dies or extrusion heads.
所述模具可以是固定直径的,也可以是变径的,以适应人体腔静脉的内径尺寸,人体腔静脉内径通常在18~32mm范围内,模具尺寸主要依据腔静脉内径尺寸以及血栓过滤器需要的径向支撑力而设计。The mold may be of a fixed diameter or a variable diameter to adapt to the inner diameter of the vena cava of the human body. The inner diameter of the vena cava is usually in the range of 18 to 32 mm, and the size of the mold is mainly based on the inner diameter of the vena cava and the needs of the thrombus filter. Designed with radial support.
一般情况下,挤出的生物可降解聚合物纤维的直径由挤出头的内径、挤出速度、挤出头沿旋转杆的移动速度和旋转杆的转速决定,有时候,也可以通过程序设计控制,比如在某些部位设计成重复走丝,以此形成不同部位具有不同或相同的纤维直径,可以实现不同部位按照计划性方案进行降解。In general, the diameter of the extruded biodegradable polymer fiber is determined by the inner diameter of the extrusion head, the extrusion speed, the moving speed of the extrusion head along the rotating rod, and the rotational speed of the rotating rod. Sometimes, it can also be programmed. Control, such as designing repeated wire runs in certain locations to form different or identical fiber diameters at different locations, allows different sites to be degraded according to a planned protocol.
本发明的生物可降解血栓过滤器可通过介入方式部署在期望的位置。 在植入体内的过程中,使过滤器处于未膨胀状态,这有利于实施微创介入,而在植入血管内后,可根据实际的血管直径,通过中心线和卡位对血栓过滤器的膨开尺寸进行调节,以使过滤器更好地贴合在血管内壁,从而不易发生移位。所述生物可降解血栓过滤器具有由过滤器材料、式样以及外形决定的机械性能和吸收性计划方案。The biodegradable thrombus filter of the present invention can be deployed in a desired location by intervention. During implantation into the body, the filter is placed in an unexpanded state, which facilitates the implementation of minimally invasive intervention, and after implantation into the blood vessel, the thrombus filter can be passed through the centerline and the card position according to the actual vessel diameter. The swell size is adjusted so that the filter fits better on the inner wall of the blood vessel, so that displacement is less likely to occur. The biodegradable thrombus filter has a mechanical properties and an absorbent plan that is determined by the filter material, style, and shape.
又一方面,本发明提供本发明的生物可降解血液血栓过滤器在制备用于预防或治疗静脉血栓栓塞症(如深静脉血栓形成和肺血栓栓塞)的器械中的用途。In still another aspect, the invention provides the use of a biodegradable blood thrombus filter of the invention in the manufacture of a device for the prevention or treatment of venous thromboembolism, such as deep vein thrombosis and pulmonary thromboembolism.
另一方面,本发明提供了本发明的生物可降解血栓过滤器在用于预防或治疗静脉血栓栓塞症如深静脉血栓形成和肺血栓栓塞中的用途。In another aspect, the invention provides the use of a biodegradable thrombus filter of the invention for the prevention or treatment of venous thromboembolism such as deep vein thrombosis and pulmonary thromboembolism.
优选地,可以将生物可降解血栓过滤器部署在IVC内,以在深静脉血栓(DVT)产生的栓子到达肺部之前捕获致命性的大栓子,实现预防、减少肺血栓栓塞(PTE)或预防、减少PTE再发。Preferably, the biodegradable thrombus filter can be deployed in the IVC to capture a fatal large embolus before the embolus produced by deep vein thrombosis (DVT) reaches the lungs, preventing and reducing pulmonary thromboembolism (PTE). Or prevent and reduce PTE recurrence.
又一方面,本发明提供了一种用于输送本发明的血栓过滤器的输送装置,其包括:血管鞘套件,该血管鞘套件包括外鞘和推送鞘,所述外鞘的末端设置有接头,所述推送鞘的末端设置有封堵帽,所述推送鞘与外鞘的尺寸相匹配,从而能够插入所述外鞘内,其特征在于,所述输送装置还包括装载管、定位鞘和牵拉丝,其中:In still another aspect, the present invention provides a delivery device for delivering a thrombus filter of the present invention, comprising: a vascular sheath kit comprising an outer sheath and a push sheath, the outer sheath being provided with a joint at the end The end of the push sheath is provided with a sealing cap, and the pushing sheath is matched with the outer sheath so as to be insertable into the outer sheath, wherein the conveying device further comprises a loading tube, a positioning sheath and Pulling wire, where:
所述装载管的一端被配置成能够插入并固定在所述外鞘的接头中,所述装载管被配置成装载未膨开状态的血栓过滤器,并且在装载管的一端插入并固定在外鞘的接头后能够使推送鞘插入其中,并能够使推送鞘推动其中装载的血栓过滤器进入外鞘并穿过外鞘进入体内;One end of the loading tube is configured to be insertable and fixable in a joint of the outer sheath, the loading tube being configured to load a thrombus filter in an unexpanded state, and inserted and fixed at an outer sheath at one end of the loading tube The connector can insert the push sheath therein and enable the push sheath to push the thrombus filter loaded therein into the outer sheath and through the outer sheath into the body;
所述定位鞘包裹在所述装载管外部并且可以在所述装置管外部自由滑动,所述定位鞘在沿着其长度方向上设置有刻度或档位,所述刻度或档位被配置成能够确定所述装载管与所述定位鞘的相对位置,从而结合推送鞘的推送程度在体外确定输送到体内的血栓过滤器的膨开尺寸;The positioning sheath is wrapped outside the loading tube and is free to slide outside the device tube, the positioning sheath being provided with a scale or gear along its length, the scale or gear being configured to enable Determining a relative position of the loading tube and the positioning sheath, thereby determining an expanded size of the thrombus filter delivered to the body in vitro in combination with a pushing degree of the pushing sheath;
所述牵拉丝被配置成在输送血栓过滤器的过程中连接所述血栓过滤器的中心线并穿过推送鞘内部在推送鞘末端由封堵帽固定,并且在所述血栓过滤器在体内达到需要的膨开尺寸后能够在体外断开上述连接。The pull wire is configured to connect the centerline of the thrombus filter during delivery of the thrombus filter and pass through the interior of the push sheath at the end of the push sheath by the closure cap, and in the thrombus filter body The above connection can be broken outside the body after reaching the desired swell size.
术语“血管鞘套件”一般是指介入操作时,引导医用导丝、球囊和其它器械进入血管病变部位的一套用具。在本发明中,为了实现输送血栓过滤器的目的,所述血管鞘套件包括外鞘和推送鞘,并且根据预期使用的部 位,所述外鞘和推送鞘可以有不同的规格,例如,具有不同的长度和直径,优选地,直径可以为2F-14F,长度可以为几厘米到八十厘米。The term "vascular sheath kit" generally refers to a kit of devices that direct medical guidewires, balloons, and other instruments into the vascular lesion site during an interventional procedure. In the present invention, for the purpose of delivering a thrombus filter, the vascular sheath kit includes an outer sheath and a push sheath, and the portion according to the intended use The outer sheath and the push sheath may have different gauges, for example, having different lengths and diameters. Preferably, the diameter may be 2F-14F and the length may be a few centimeters to eighty centimeters.
在本发明的一个实施方案中,所述推送鞘由可推入部分和不可推入部分组成,所述可推入部分为推送鞘能够插入外鞘、装载管和定位鞘的部分,在所述可推入部分全部插入外鞘、装载管和定位鞘之后,所述不可推入部分抵住装载管和/或定位鞘;其中:In one embodiment of the invention, the push sheath is comprised of a pushable portion that is a portion of the push sheath that can be inserted into the outer sheath, the loading tube, and a positioning sheath, and the non-pushable portion After the pushable portion is fully inserted into the outer sheath, the loading tube and the positioning sheath, the non-pushable portion abuts the loading tube and/or the positioning sheath; wherein:
所述定位鞘的长度≤所述装载管插入接头后剩余的长度,The length of the positioning sheath ≤ the length remaining after the loading tube is inserted into the joint,
所述推送鞘可推入部分的长度>所述外鞘的长度,和The pushing sheath can push the length of the portion > the length of the outer sheath, and
所述装载管插入接头后剩余的长度<所述推送鞘可推入部分与外鞘的长度差<所述装载管插入接头后剩余的长度+所述定位鞘的长度。The length remaining after the loading tube is inserted into the joint < the length difference between the push sheath pushable portion and the outer sheath < the length remaining after the loading tube is inserted into the joint + the length of the positioning sheath.
优选地,其中所述装载管和定位鞘均为圆柱管。Preferably, wherein the loading tube and the positioning sheath are both cylindrical tubes.
优选地,其中所述外鞘、推送鞘、装载管和/或定位鞘由包含聚四氟乙烯的材料制成。Preferably, wherein the outer sheath, the push sheath, the loading tube and/or the positioning sheath are made of a material comprising polytetrafluoroethylene.
在本发明的一个实施方案中,所述定位鞘上有刻度或档位的部分为透明的、半透明的或为镂空的,以便于观察所述装载管与所述定位鞘的相对位置。In one embodiment of the invention, the portion of the positioning sheath having the scale or gear is transparent, translucent or hollow to facilitate viewing of the relative position of the loading tube to the positioning sheath.
再一方面,本发明提供了一种血栓过滤系统,其包括本发明所述的生物可降解血栓过滤器和本发明所述的输送装置。In a further aspect, the present invention provides a thrombus filtration system comprising the biodegradable thrombus filter of the present invention and the delivery device of the present invention.
又一方面,本发明还提供了一种本发明的输送装置或血栓过滤系统的使用方法,包括以下步骤:In still another aspect, the present invention also provides a method of using the delivery device or thrombus filtration system of the present invention, comprising the steps of:
1.用装载管装载未膨开状态的血栓过滤器;1. Loading the unexpanded thrombus filter with a loading tube;
2.用牵拉丝连接所述血栓过滤器的中心线并穿过推送鞘内部在推送鞘末端由封堵帽固定;2. Connecting the centerline of the thrombus filter with a pull wire and passing through the interior of the push sheath at the end of the push sheath by the closure cap;
3.将所述装载管的一端插入并固定在所述外鞘的接头中;3. Inserting and fixing one end of the loading tube into the joint of the outer sheath;
4.将推送鞘插入装载管内,并推动装载管中的血栓过滤器进入外鞘并穿过外鞘进入体内;4. Insert the push sheath into the loading tube and push the thrombus filter in the loading tube into the outer sheath and through the outer sheath into the body;
5.通过定位鞘上的刻度或档位确定所述装载管与所述定位鞘的相对位置,从而结合推送鞘的推送程度在体外确定输送到体内的血栓过滤器的膨开尺寸;5. determining the relative position of the loading tube and the positioning sheath by positioning the scale or gear on the sheath, thereby determining the expansion size of the thrombus filter delivered to the body in vitro in combination with the pushing degree of the pushing sheath;
6.在所述血栓过滤器在体内达到需要的膨开尺寸后,在体外断开牵拉丝的连接,并将输送装置回撤到体外。6. After the thrombus filter reaches the desired swell size in the body, the wire is disconnected in vitro and the delivery device is withdrawn to the outside of the body.
在本发明优选的实施方案中,本发明的输送装置或血栓过滤系统的 使用方法包括先在体外进行操作以确定血栓过滤器完全被推出外鞘以及处于不同膨开尺寸时,装载管未插入接头的端部在定位鞘上的刻度或档位,然后在输送所述血栓过滤器到体内的过程中,反过来通过已经确定的不同刻度和档位来确定血栓过滤器被输送到体内的状态和膨开的尺寸。In a preferred embodiment of the invention, the delivery device or thrombus filtration system of the invention The method of use includes first operating in vitro to determine that the thrombus filter is fully pushed out of the outer sheath and at different expansion sizes, the end of the loading tube that is not inserted into the joint is on the scale or gear on the positioning sheath, and then the thrombus is delivered During the filter to the body, the different states and gears that have been determined are in turn determined by the state in which the thrombus filter is delivered to the body and the size of the expansion.
优选地,本发明的输送装置或血栓过滤系统的使用方法包括:先在体外进行以下操作,以确定血栓过滤器完全被推出外鞘以及处于不同膨开尺寸时,装载管未插入接头的端部在定位鞘上的刻度或档位:Preferably, the method of using the delivery device or thrombus filtration system of the present invention comprises: first performing the following operations in vitro to determine that the thrombus filter is fully pushed out of the outer sheath and that the loading tube is not inserted into the end of the joint when in different expanded sizes The scale or gear on the positioning sheath:
1.将未膨开的血栓过滤器插入装载管中,露出血栓过滤器的中心线的尾部;1. Insert the unexpanded thrombus filter into the loading tube to expose the tail of the centerline of the thrombus filter;
2.通过例如打活结的方式将牵拉丝固定在血栓过滤器中心线的尾部,如尾端孔中;2. Fixing the pull wire to the tail of the center line of the thrombus filter, such as the end hole, by, for example, activating the knot;
3.将牵拉丝从推送鞘的尖端穿进并从推送鞘的末端穿出,拉紧牵拉丝,直到推送鞘的尖端与血栓过滤器的尾部接触,旋紧封堵帽,将牵拉丝固定,此时,推送鞘和装载管被牵拉丝和血栓过滤器连成一体;3. Pass the pulling wire from the tip of the push sheath and out through the end of the push sheath, and tighten the pull wire until the tip of the push sheath contacts the tail of the thrombus filter, tighten the cap and pull The wire is fixed, at this time, the push sheath and the loading tube are connected by the pulling wire and the thrombus filter;
4.将装载管的一端插入并固定在外鞘的接头中;4. Insert one end of the loading tube into the joint of the outer sheath;
5.移动定位鞘使其上的刻度1或档位1到达装载管未插入接头的端部,推进推送鞘直到推送鞘的不可推入部分被定位鞘卡住,此时血栓过滤器有一部分被推出外鞘;5. Move the positioning sheath so that the scale 1 or gear 1 on the end reaches the end of the loading tube that is not inserted into the joint, and pushes the push sheath until the non-pushable portion of the push sheath is caught by the positioning sheath, at which point the thrombus filter is partially Launching the outer sheath;
6.固定推送鞘,回拉外鞘使血栓过滤器刚好被完全推出外鞘,此时装载管未插入接头的端部到达定位鞘上的刻度2或档位2;6. Fix the push sheath, pull back the outer sheath so that the thrombus filter is just fully pushed out of the outer sheath, at this time the loading tube is not inserted into the end of the joint to reach the scale 2 or gear 2 on the positioning sheath;
7.固定外鞘,回推定位鞘使得牵拉丝牵拉中心线并使血栓过滤器膨开到由不同卡位卡住时所限定的不同尺寸,记录此时装载管未插入接头的端部分别到达定位鞘上的特定刻度或档位;7. Fix the outer sheath, push back the positioning sheath so that the pulling wire pulls the center line and expands the thrombus filter to different sizes defined by the different card positions, and records that the loading tube is not inserted into the end of the joint at this time. Reaching a specific scale or gear position on the positioning sheath, respectively;
然后,在输送所述血栓过滤器到体内的过程中,重复上述操作步骤1-7,不同的是,反过来通过已经确定的不同刻度和档位来确定血栓过滤器被输送到体内的状态和膨开的尺寸,当所述血栓过滤器膨开到适当尺寸后,进行以下操作步骤:Then, in the process of delivering the thrombus filter into the body, the above steps 1-7 are repeated, except that, in turn, the different scales and gear positions that have been determined are used to determine the state in which the thrombus filter is delivered to the body and The size of the expansion, after the thrombus filter is expanded to an appropriate size, the following steps are performed:
8.固定外鞘,推进推送鞘使装载管未插入接头的端部还原到定位鞘上的刻度2或档位2的位置,此时牵拉丝的活结露出外鞘,并且血栓过滤器的膨开尺寸已经被固定;8. Fix the outer sheath and push the push sheath to restore the end of the loading tube that is not inserted into the joint to the position of the scale 2 or the position 2 on the positioning sheath. At this time, the slip of the pulling wire exposes the outer sheath, and the expansion of the thrombus filter The opening size has been fixed;
9.旋下封堵帽,拉动牵拉丝使活结打开,回撤牵拉丝,血栓过滤器被释放; 9. Unscrew the sealing cap, pull the pulling wire to open the slip joint, withdraw the pulling wire, and release the thrombus filter;
10.回撤推送鞘、外鞘等输送装置。10. Retract the delivery device such as the sheath and sheath.
本发明通过使用生物可降解原材料,利用四轴快速成型系统制备出不同结构及形状的具有较好的可膨胀性能的生物可降解血栓过滤器。本发明的生物可降解血栓过滤器及其制备方法具有以下优点:The present invention prepares a biodegradable thrombus filter having better swellability and different structures and shapes by using a bio-degradable raw material by using a four-axis rapid prototyping system. The biodegradable thrombus filter of the present invention and the preparation method thereof have the following advantages:
1.本发明的生物可降解血栓过滤器具有两个过滤网,从而可以更好地捕捉或者抑制血管内的栓子而暂时防止PTE,可起到临时性的保护作用,完成使命后自行消失,不会产生如传统VCF所示的对终末器官不利的影响,体内留置时间短,避免了传统永久性滤器由于滤器本身造成的栓塞问题,以及临时性和可回收滤器在置入和回收过程中产生的多种并发症。1. The biodegradable thrombus filter of the present invention has two kinds of filters, so that the emboli in the blood vessel can be better captured or suppressed, and the PTE can be temporarily prevented, which can temporarily protect the body and disappear after completing the mission. It does not produce adverse effects on the terminal organs as shown by the traditional VCF, and the indwelling time in the body is short, avoiding the embolic problem caused by the conventional permanent filter due to the filter itself, and the temporary and recyclable filter during the insertion and recovery process. A variety of complications.
2.本发明的生物可降解血栓过滤器可以通过选用原材料、结构设计及外形处理等实现在血管内的计划性降解。2. The biodegradable thrombus filter of the present invention can achieve planned degradation in blood vessels by selecting raw materials, structural design, and shape treatment.
3.本发明的生物可降解血栓过滤器具有变化的可膨胀系数,因而其横截面尺寸可以根据不同的血管直径进行适应性地改变,从而适用范围更广。在植入体内的过程中,使过滤器处于未膨胀状态,这有利于实施微创介入,而在植入血管内后,可根据实际的血管直径,通过中心线和卡位对血栓过滤器的膨开尺寸进行调节,以使过滤器更好地贴合在血管内壁,从而在使用过程中不易发生移位、静脉损伤或穿孔等。3. The biodegradable thrombus filter of the present invention has a variable coefficient of expansion, and thus its cross-sectional size can be adaptively changed according to different blood vessel diameters, thereby being more applicable. During implantation into the body, the filter is placed in an unexpanded state, which facilitates the implementation of minimally invasive intervention, and after implantation into the blood vessel, the thrombus filter can be passed through the centerline and the card position according to the actual vessel diameter. The swell size is adjusted so that the filter fits better on the inner wall of the blood vessel, so that displacement, vein damage or perforation is less likely to occur during use.
4.本发明创新的牵引膨胀设计解决了由现有生物可降解材料制备的滤器在体内环境下的释放问题,同时通过膨胀还起到固定滤器的作用,防止移位的发生,降低产品风险。4. The innovative traction expansion design of the invention solves the problem of release of the filter prepared by the existing biodegradable material in the internal environment, and at the same time acts to fix the filter by expansion, preventing the occurrence of displacement and reducing the product risk.
5.本发明的生物可降解血栓过滤器的制备方法与现有滤器的制备工艺(如激光焊接、激光切割和编制技术等)相比,操作简单、快速高效、更改容易、且成本较低,适用于产品的大批量生产。5. The preparation method of the biodegradable thrombus filter of the present invention is simpler, faster and more efficient, easier to change, and lower in cost than the preparation process of the existing filter (such as laser welding, laser cutting and braiding technology). Suitable for mass production of products.
6.本发明的输送系统不仅能够实现本发明的血栓过滤器的微创植入,并且可以在体外确定体内植入过程中所述血栓过滤器的输送状态和膨开尺寸,输送方法简单易操作,输送过程准确、可控。本发明还实现了一个型号的输送装置可以用于输送多种长度规格的血栓过滤器,并由此可以减少库存量。6. The delivery system of the present invention can not only realize the minimally invasive implantation of the thrombus filter of the present invention, but also can determine the delivery state and the expansion size of the thrombus filter during implantation in vivo in vitro, and the delivery method is simple and easy to operate. The conveying process is accurate and controllable. The present invention also enables a single type of delivery device that can be used to deliver a variety of length gauge thrombus filters, thereby reducing inventory.
附图的简要说明BRIEF DESCRIPTION OF THE DRAWINGS
图1示出了本发明实施例1制备得到的一种生物可降解血栓过滤器展开的平面结构示意图; 1 is a schematic plan view showing the development of a biodegradable thrombus filter prepared in Example 1 of the present invention;
图2示出了图1所示的生物可降解血栓过滤器的立体图;Figure 2 is a perspective view of the biodegradable thrombus filter of Figure 1;
图3示出了本发明实施例2制备得到的一种生物可降解血栓过滤器的立体图;3 is a perspective view showing a biodegradable thrombus filter prepared in Example 2 of the present invention;
图4A示出了实施例3的输送装置的组成和结构;图4B例示了几种牵拉丝打活结的方法;4A shows the composition and structure of the conveying device of Embodiment 3; FIG. 4B illustrates several methods for pulling the wire to tie the knot;
图5A~图5E示出了实施例3的血栓过滤器的装载方法示意图;其中,图5A~图5E依次示出了血栓过滤器压缩入装载管,并通过牵拉丝与推送鞘连为一体的过程;5A to 5E are views showing a loading method of the thrombus filter of Embodiment 3; wherein, Figs. 5A to 5E sequentially show that the thrombus filter is compressed into the loading tube, and is connected to the push sheath by the pulling wire. the process of;
图6A~图6G依次示出了实施例3的血栓过滤器的输送操作步骤示意图;其中,图6A示出了装载管的一端插入外鞘的接头的状态图;图6B示出了推进推送鞘,使血栓过滤器一部分裸露在血管中,装载管末端在定位鞘的D档的状态图;图6C示出了固定推送鞘,回拉外鞘,使装载管未插入接头的端部到达定位鞘的0档,血栓过滤器恰好全部暴露在血管中的状态图;图6D示出了固定外鞘,回推定位鞘使装载管未插入接头的端部到达定位鞘1档(也可以根据需要选择不同档位),此时装载管与推送鞘之间有一定的位移,血栓过滤器膨开一定的直径,并被中心线上的卡位固定;图6E示出了固定外鞘,推进推送鞘使牵拉丝的活结露出外鞘的状态图,此时血栓过滤器的膨开直径已经被固定;图6F示出了旋下封堵帽,拉动一根牵拉丝,使结节打开,释放血栓过滤器的状态图;图6G示出了回撤推送鞘、外鞘等输送装置的状态图;6A to 6G are views showing sequentially a transport operation procedure of the thrombus filter of Embodiment 3; wherein, FIG. 6A shows a state diagram of a joint in which one end of the loading tube is inserted into the outer sheath; and FIG. 6B shows a push push sheath in FIG. a portion of the thrombus filter exposed in the blood vessel, the end of the loading tube in the D position of the positioning sheath; Figure 6C shows the fixed push sheath, pull back the outer sheath, so that the loading tube is not inserted into the end of the joint to reach the positioning sheath In the 0th position, the thrombus filter is exactly exposed to the state diagram of the blood vessel; Figure 6D shows the fixed outer sheath, and the push-back positioning sheath causes the loading tube to be inserted into the end of the joint to reach the positioning sheath 1 (can also be selected as needed) Different gear positions), there is a certain displacement between the loading tube and the push sheath, the thrombus filter expands a certain diameter, and is fixed by the card position on the center line; FIG. 6E shows the fixed outer sheath, the push push sheath A state diagram in which the slip of the pulling wire is exposed to the outer sheath, at which time the expanded diameter of the thrombus filter has been fixed; FIG. 6F shows that the sealing cap is unscrewed, pulling a pulling wire to open the nodule, releasing State diagram of the thrombus filter; Figure 6G shows The state of FIG retracement push sheath, the outer sheath of the delivery device and the like;
图7示出了本发明实施例1的生物可降解血栓过滤器在动物下腔静脉内植入过程的造影图,图中4个黑点是4处金丝标记,图中血栓过滤器还没有完全膨开;Figure 7 is a view showing the contrast of the biodegradable thrombus filter of the embodiment 1 of the present invention in the inferior vena cava implantation process of the animal. The four black spots in the figure are four gold wire marks, and the thrombus filter in the figure is not yet Fully expanded
图8示出了本发明实施例1的生物可降解血栓过滤器在动物下腔静脉内植入过程的造影图,图中4个黑点是4处金丝标记,图中血栓过滤器处于膨开状态;Figure 8 is a view showing the contrast of the biodegradable thrombus filter of the embodiment 1 of the present invention in the inferior vena cava implantation process of the animal. In the figure, four black spots are four gold wire marks, and the thrombus filter is inflated. Open state
图9示出了本发明实施例1的生物可降解血栓过滤器在植入动物体内后2周复查的造影图,图中4个黑点是4处金丝标记,图中血栓过滤器为膨开状态,没有发生迁移。Figure 9 is a photographic diagram of the biodegradable thrombus filter of Example 1 of the present invention after 2 weeks of implantation in an animal. The four black spots in the figure are four gold wire marks, and the thrombus filter is inflated. In the open state, no migration occurred.
实施发明的最佳方式The best way to implement the invention
下面结合如下实施例对本发明做更进一步的详细说明,其并不意味着 限制本发明。The present invention will be further described in detail below with reference to the following examples, which does not mean Limit the invention.
实施例1Example 1
适用于下腔静脉的生物可降解血栓过滤器,用聚己内酯作为原材料,具体加工步骤如下:Biodegradable thrombus filter for the inferior vena cava, using polycaprolactone as a raw material, the specific processing steps are as follows:
1)采用3D打印技术制备外径分别为20mm、25mm、30mm的圆筒状模具;1) using a 3D printing technique to prepare a cylindrical mold having outer diameters of 20 mm, 25 mm, and 30 mm, respectively;
2)采用计算机设计生物可降解聚合物纤维采用圆弧形走丝方式沉积成花瓣形式样的程序;其中设计成一个多孔过滤网的顶端在四轴快速成型系统上直接成型;2) using a computer designed biodegradable polymer fiber to be deposited into a petal form by a circular arc-like method; wherein the top end of the porous filter is designed to be directly formed on a four-axis rapid prototyping system;
3)将所述模具套在四轴快速成型系统的第四轴系统的旋转杆上进行固定,使其能够在计算机控制系统的控制下随第四轴旋转杆作正向或反向转动;并将聚己内酯加入四轴快速成型系统的分配系统内;3) fixing the mold on the rotating rod of the fourth shaft system of the four-axis rapid prototyping system, so that it can rotate forward or reverse with the fourth shaft rotating rod under the control of the computer control system; Adding polycaprolactone to the distribution system of the four-axis rapid prototyping system;
4)按照步骤2)设计的程序通过计算机控制系统控制X-Y-Z定位系统和第四轴系统,使分配系统精确地按照预先设计的生物可降解聚合物纤维的沉积式样挤出聚合物纤维,沉积在第四轴上可以旋转的模具的特定位置,从而制备出多孔的滤器主体前体;4) According to the procedure designed in step 2), the XYZ positioning system and the fourth axis system are controlled by the computer control system, so that the distribution system accurately extrudes the polymer fiber according to the pre-designed deposition pattern of the biodegradable polymer fiber, and deposits it in the first a specific position of the mold that can be rotated on the four axes to prepare a porous filter body precursor;
5)将冷却后的步骤4)制备的滤器主体前体(其平面展开图见图1)从模具上取下来,用聚己内酯纤维将滤器主体前体的另一端串起来形成另一个多孔过滤网104的顶端。将中心线102的一端连接到一个多孔过滤网104的顶端,中心线102的另一端经过滤器100内部延伸通过另一个多孔过滤网104的顶端至过滤器100的外部,其中,所述中心线102上设置有三个卡位105,通过中心线102和卡位105实现过滤器100的牵拉膨胀并且过滤器100的膨开尺寸可调,从而得到具有所需外形的血栓过滤器100(其立体图见图2)。5) The cooled filter body precursor prepared in step 4) (the planar development view is shown in Fig. 1) is taken out from the mold, and the other end of the filter body precursor is stringed with polycaprolactone fibers to form another porous The top end of the filter 104. One end of the centerline 102 is coupled to the top end of a porous filter screen 104, and the other end of the centerline 102 extends through the interior of the filter 100 through the top end of another porous filter screen 104 to the exterior of the filter 100, wherein the centerline 102 Three latching positions 105 are provided thereon, the pulling expansion of the filter 100 is achieved by the center line 102 and the latching position 105, and the expansion size of the filter 100 is adjustable, thereby obtaining a thrombus filter 100 having a desired shape (see a perspective view thereof). figure 2).
6)用金丝110将图2箭头所示的四个部分分别结扎固定,裸露出来的金丝110的长度根据静脉壁的厚度来定。金丝110可以起到稳定血栓过滤器100的作用,并且在植入体内后可以起到显影及固定血栓过滤器的作用。6) The four portions shown by the arrows in Fig. 2 are respectively ligated and fixed by the gold wire 110, and the length of the exposed gold wire 110 is determined according to the thickness of the vein wall. The gold wire 110 can function to stabilize the thrombus filter 100 and can function to develop and fix a thrombus filter after being implanted in the body.
如图2所示,所述血栓过滤器100包括滤器主体101和中心线102,所述滤器主体101包括多孔管状支架体103和位于所述多孔管状支架体103两端的两个多孔过滤网104,所述中心线102上设置有两个以上卡位 105。As shown in FIG. 2, the thrombus filter 100 includes a filter body 101 and a centerline 102, the filter body 101 including a porous tubular stent body 103 and two porous filter screens 104 at both ends of the porous tubular stent body 103, More than two card positions are arranged on the center line 102 105.
实施例2Example 2
一种生物可降解血栓过滤器,用聚乳酸作为原材料,具体加工步骤如下:A biodegradable thrombus filter using polylactic acid as a raw material, the specific processing steps are as follows:
1)采用3D打印技术制备橄榄球形空心模具;1) preparing a rugby-shaped hollow mold by using 3D printing technology;
2)采用计算机设计生物可降解聚合物纤维采用Z字形走丝方式沉积成花瓣形式样的程序;其中设计成两个多孔过滤网的顶端均在四轴快速成型系统上直接成型;2) The computer designed biodegradable polymer fiber is deposited into a petal form by a zigzag wire; wherein the tops of the two porous filters are directly formed on the four-axis rapid prototyping system;
3)将所述模具套在四轴快速成型系统的第四轴系统的旋转杆上进行固定,使其能够在计算机控制系统的控制下随第四轴旋转杆作正向或反向转动;并将聚乳酸加入四轴快速成型系统的分配系统内;3) fixing the mold on the rotating rod of the fourth shaft system of the four-axis rapid prototyping system, so that it can rotate forward or reverse with the fourth shaft rotating rod under the control of the computer control system; Adding polylactic acid to the distribution system of the four-axis rapid prototyping system;
4)按照步骤2)设计的程序通过计算机控制系统控制X-Y-Z定位系统和第四轴系统,使分配系统精确地按照预先设计的生物可降解聚合物纤维的沉积式样挤出聚合物纤维,沉积在第四轴上可以旋转的模具的特定位置,从而制备出多孔的滤器主体前体;4) According to the procedure designed in step 2), the XYZ positioning system and the fourth axis system are controlled by the computer control system, so that the distribution system accurately extrudes the polymer fiber according to the pre-designed deposition pattern of the biodegradable polymer fiber, and deposits it in the first a specific position of the mold that can be rotated on the four axes to prepare a porous filter body precursor;
5)将冷却后的步骤4)制备的滤器主体前体从模具上取下来。将中心线202的一端连接到一个多孔过滤网204的顶端,中心线202的另一端经过滤器200内部延伸通过另一个多孔过滤网204的顶端至过滤器200的外部,其中,所述中心线202上设置有卡位205,通过中心线202和卡位205实现过滤器200的牵拉膨胀并且过滤器200的膨开尺寸可调,从而得到具有所需外形的血栓过滤器200(其立体图见图3)。5) The filter body precursor prepared in the step 4) after cooling is taken out from the mold. One end of the centerline 202 is coupled to the top end of a porous filter screen 204, and the other end of the centerline 202 extends through the interior of the filter 200 through the top end of another porous filter screen 204 to the exterior of the filter 200, wherein the centerline 202 A card slot 205 is disposed thereon, and the tension expansion of the filter 200 is achieved by the center line 202 and the card position 205 and the expansion size of the filter 200 is adjusted, thereby obtaining a thrombus filter 200 having a desired shape (the perspective view thereof is shown in FIG. 3).
如图3所示,所述血栓过滤器200包括滤器主体201和中心线202,所述滤器主体201包括多孔管状支架体203和位于所述多孔管状支架体203两端的两个多孔过滤网204,所述中心线202上设置有两个以上卡位205。As shown in FIG. 3, the thrombus filter 200 includes a filter body 201 and a centerline 202, the filter body 201 including a porous tubular stent body 203 and two porous filter screens 204 at opposite ends of the porous tubular stent body 203, Two or more card positions 205 are disposed on the center line 202.
实施例3Example 3
生物可降解血栓过滤器输送装置及其使用方法:Biodegradable thrombus filter delivery device and method of use thereof:
所使用的输送装置由10F血管鞘套件(购自COOK Medical)(包括外鞘1和推送鞘2)、10F装载管3、定位鞘4和直径0.3mm尼龙牵拉丝5组成(见图4A)。 The delivery device used consisted of a 10F vascular sheath kit (available from COOK Medical) (including outer sheath 1 and push sheath 2), a 10F loading tube 3, a positioning sheath 4, and a 0.3 mm diameter nylon pull wire 5 (see Figure 4A). .
血管鞘材料:鞘管6:聚四氟乙烯、硫酸钡;止血阀7:高密度聚乙烯、硅胶;侧臂连接管8:聚氯乙烯;接头9:聚碳酸酯。装载管3材料:聚四氟乙烯。定位鞘4材料:聚四氟乙烯。Vascular sheath material: sheath 6: polytetrafluoroethylene, barium sulfate; hemostatic valve 7: high density polyethylene, silica gel; side arm connecting tube 8: polyvinyl chloride; joint 9: polycarbonate. Loading tube 3 material: polytetrafluoroethylene. Positioning sheath 4 material: polytetrafluoroethylene.
植入血栓过滤器11前,首先对腔静脉造影,测量靶部位内径尺寸,确定血栓过滤器规格。根据所要输送的血栓过滤器的长度,先在体外进行操作以确定血栓过滤器完全被推出外鞘以及处于不同膨开尺寸时,装载管未插入接头的端部在定位鞘上的刻度或档位。Before the thrombus filter 11 is implanted, the vena cava angiography is first performed, and the inner diameter of the target site is measured to determine the thrombus filter size. Depending on the length of the thrombus filter to be delivered, it is first operated in vitro to determine the scale or position of the end of the loading tube that is not inserted into the sheath when the thrombus filter is fully pushed out of the sheath and at different expansion sizes. .
使用时,需要先将血栓过滤器11装进装载管3中,图5A~图5E示出了血栓过滤器的装载方法示意图。具体操作为:将血栓过滤器11压缩入装载管3中,露出血栓过滤器中心线12的尾部。通过打活结(如图4B所示)的方式将牵拉丝5固定在血栓过滤器中心线12的尾端孔13中。将牵拉丝5穿进并穿出推送鞘2,拉紧牵拉丝5,直到推送鞘的尖端挨上血栓过滤器11的尾部,旋紧封堵帽14,将牵拉丝5固定,此时,推送鞘2和装载管3被牵拉丝5和血栓过滤器11连成一体。In use, the thrombus filter 11 needs to be loaded into the loading tube 3 first, and FIGS. 5A to 5E show schematic views of the loading method of the thrombus filter. The specific operation is to compress the thrombus filter 11 into the loading tube 3 to expose the tail of the thrombus filter center line 12. The pulling wire 5 is fixed in the trailing end hole 13 of the thrombus filter center line 12 by means of activating the knot (as shown in Fig. 4B). The drawing wire 5 is inserted into and out of the pushing sheath 2, and the pulling wire 5 is tightened until the tip end of the pushing sheath is attached to the tail of the thrombus filter 11, and the sealing cap 14 is screwed to fix the pulling wire 5, which At this time, the push sheath 2 and the loading tube 3 are integrally connected by the pulling wire 5 and the thrombus filter 11.
图6A~图6G依次示出了血栓过滤器的输送操作步骤:将装载管3的一端插入外鞘1内至鲁尔接头9的端部(见图6A)。移动定位鞘4使其D档到达装载管3未插入接头的端部,推进推送鞘2直到被定位鞘4卡住,此时血栓过滤器11有1/3裸露在血管内(见图6B)。固定推送鞘2,回拉外鞘1使装载管3未插入接头的端部到达定位鞘4的0档,此时血栓过滤器11被完全暴露在血管中(见图6C)。固定外鞘1,回推定位鞘4使装载管3未插入接头的端部到达如定位鞘4的1档(根据需要可选择不同档位),此时中心线12上的卡位会被拉出血栓过滤器11的尾端并卡在血栓过滤器11外,血栓过滤器11由此膨开一定的直径(见图6D)。固定外鞘1,推进推送鞘2使牵拉丝5的活结露出外鞘1(见图6E)。旋下封堵帽14,拉动其中一根牵拉丝5,结节打开,回撤牵拉丝5,血栓过滤器11被释放(见图6F)。回撤推送鞘2、外鞘1等输送装置(见图6G)。6A to 6G sequentially show the transporting operation of the thrombus filter: one end of the loading tube 3 is inserted into the outer sheath 1 to the end of the luer 9 (see Fig. 6A). The positioning sheath 4 is moved so that the D position reaches the end of the loading tube 3 that is not inserted into the joint, and the push sheath 2 is advanced until it is caught by the positioning sheath 4, at which time 1/3 of the thrombus filter 11 is exposed in the blood vessel (see Fig. 6B). . The push sheath 2 is fixed, and the outer sheath 1 is pulled back so that the end of the loading tube 3 not inserted into the joint reaches the 0 position of the positioning sheath 4, at which time the thrombus filter 11 is completely exposed to the blood vessel (see Fig. 6C). The outer sheath 1 is fixed, and the positioning sheath 4 is pushed back so that the end of the loading tube 3 not inserted into the joint reaches the first gear such as the positioning sheath 4 (the different gear positions can be selected as needed), and the card position on the center line 12 is pulled. The tail end of the thrombus filter 11 is pulled out of the thrombus filter 11, and the thrombus filter 11 is thereby expanded to a certain diameter (see Fig. 6D). The outer sheath 1 is fixed, and the push sheath 2 is advanced to expose the slip of the pull wire 5 to the outer sheath 1 (see Fig. 6E). The sealing cap 14 is unscrewed, one of the pulling wires 5 is pulled, the nodule is opened, the pulling wire 5 is withdrawn, and the thrombus filter 11 is released (see Fig. 6F). The delivery device such as the push sheath 2 and the outer sheath 1 is withdrawn (see Fig. 6G).
实施例4Example 4
生物可降解血栓过滤器体内实验,实验采用猪下腔静脉模型。具体过程如下:In vivo experiments with biodegradable thrombus filters were performed using a porcine inferior vena cava model. The specific process is as follows:
实验选用健康成年中华小型猪模型(购自中国农业大学实验动物中心),通过穿刺股总静脉处建立静脉通路,之后行下腔静脉造影,确定血 栓过滤器规格及植入部位,按照输送装置使用方法将血栓过滤器植入指定的部位。The experiment selected a healthy adult Chinese miniature pig model (purchased from the Experimental Animal Center of China Agricultural University), established a venous access through the common femoral vein, and then underwent inferior vena cava angiography to determine blood. The plug filter specification and the implant site are used to implant the thrombus filter into the designated site according to the method of use of the delivery device.
在植入体内的过程中,首先使血栓过滤器处于未膨开状态,待到达待放入的位置后,通过牵拉中心线使血栓过滤器逐渐膨开,并利用中心线上不同的卡位对中心线进行固定,从而调整血栓过滤器的形状和膨开尺寸,使血栓过滤器与血管壁更加贴合。In the process of implanting the body, the thrombus filter is first placed in an unexpanded state, and after reaching the position to be placed, the thrombus filter is gradually expanded by pulling the center line, and different card positions on the center line are utilized. Fix the centerline to adjust the shape and size of the thrombus filter so that the thrombus filter fits more closely with the vessel wall.
血栓过滤器植入后造影评价血栓过滤器植入部位管腔通畅性。2周后,对实验猪行下腔静脉造影,观察血栓过滤器是否还在原来的位置并保持膨开的状态。The thrombus filter was used to evaluate the lumen patency of the thrombus implant site after embolization. Two weeks later, the experimental pigs underwent an inferior vena cava angiography to see if the thrombus filter was still in its original position and remained in an expanded state.
其中,图7示出了实施例1的生物可降解血栓过滤器在动物下腔静脉内植入过程的造影图,图中4个黑点是4处金丝标记,图中血栓过滤器还没有完全膨开。图8示出了所述血栓过滤器处于膨开状态的造影图。在血栓过滤器植入动物体内后2周复查,造影图见图9,可以看出图中血栓过滤器仍然处于膨开状态,并且没有发生迁移,血管没有发生损伤或穿孔。 7 is a contrast diagram of the biodegradable thrombus filter of Example 1 implanted in the inferior vena cava of an animal. The four black spots in the figure are four gold wire marks, and the thrombus filter is not yet in the figure. Fully expanded. Figure 8 shows a contrast image of the thrombus filter in an expanded state. After the thrombus filter was implanted in the animal for 2 weeks, the angiogram is shown in Fig. 9. It can be seen that the thrombus filter is still in an expanded state, and no migration occurs, and the blood vessel is not damaged or perforated.

Claims (17)

  1. 一种生物可降解血栓过滤器,其包括滤器主体和中心线,所述滤器主体包括多孔管状支架体和位于所述多孔管状支架体两端的两个多孔过滤网,所述多孔管状支架体和多孔过滤网是由生物可降解聚合物纤维按照预先设计的式样沉积而一体成型的,所述中心线由生物可降解聚合物制成;A biodegradable thrombus filter comprising a filter body and a centerline, the filter body comprising a porous tubular stent body and two porous filter meshes at opposite ends of the porous tubular stent body, the porous tubular stent body and porous The filter mesh is integrally formed from a biodegradable polymer fiber deposited in a pre-designed form, the centerline being made of a biodegradable polymer;
    其中,所述中心线的一端与一个多孔过滤网的顶端相连,并经由过滤器内部延伸通过另一个多孔过滤网的顶端至过滤器的外部,所述中心线上设置有两个以上卡位,通过中心线及卡位能够实现过滤器的牵拉膨胀并且过滤器的膨开尺寸可调。Wherein one end of the centerline is connected to the top end of a porous filter and extends through the inside of the filter through the top end of another porous filter to the outside of the filter, and the center line is provided with more than two card positions. The tension expansion of the filter can be achieved by the center line and the card position and the expansion size of the filter can be adjusted.
  2. 根据权利要求1所述的生物可降解血栓过滤器,其中,所述多孔管状支架体的横截面为圆形、多边形或不规则图形。The biodegradable thrombus filter according to claim 1, wherein the porous tubular stent body has a circular, polygonal or irregular pattern in cross section.
  3. 根据权利要求1所述的生物可降解血栓过滤器,其中,所述血栓过滤器的外形为圆球形、橄榄球形、灯笼形、离心管形、或不规则形状。The biodegradable thrombus filter according to claim 1, wherein the thrombus filter has a spherical shape, a rugby shape, a lantern shape, a centrifuge tube shape, or an irregular shape.
  4. 根据权利要求1所述的生物可降解血栓过滤器,其中,所述预先设计的式样为花瓣形式样,优选地,所述花瓣形式样由直线形、Z字形和/或圆弧形走丝方沉积出来;The biodegradable thrombus filter according to claim 1, wherein said pre-designed pattern is in the form of a petal, preferably, said petal form is formed by a straight line, a zigzag shape and/or a circular arc shape. Deposited
    优选地,所述多孔管状支架体和/或多孔过滤网的生物可降解聚合物纤维与纤维之间呈直角结合、锐角结合、钝角结合、有弧度的圆角结合或者它们的组合;Preferably, the porous tubular stent body and/or the biodegradable polymer fiber of the porous filter mesh are combined with the fibers at right angles, acute angles, obtuse angles, rounded corners, or combinations thereof;
    优选地,所述多孔管状支架体和/或多孔过滤网的生物可降解聚合物纤维的横截面为圆形、多边形或不规则形状;Preferably, the cross section of the porous tubular stent body and/or the porous filter web biodegradable polymer fiber is circular, polygonal or irregular;
    优选地,所述多孔管状支架体和/或多孔过滤网的生物可降解聚合物纤维具有固定的或变化的直径,优选地,所述生物可降解聚合物纤维的直径为50纳米至1毫米,更优选地,所述生物可降解聚合物纤维的直径为100微米至500微米。Preferably, the porous tubular stent body and/or the biodegradable polymer fiber of the porous filter mesh have a fixed or varying diameter, preferably, the biodegradable polymer fiber has a diameter of 50 nm to 1 mm. More preferably, the biodegradable polymer fiber has a diameter of from 100 micrometers to 500 micrometers.
  5. 根据权利要求1至4中任一项所述的生物可降解血栓过滤器,其中,所述生物可降解聚合物选自以下的一种或多种:聚乳酸(PLA)、左旋聚乳酸(PLLA)、右旋聚乳酸(PDLA)、聚乙二醇-聚羟基乙酸(PGA)、聚己酸内酯(PCL)、聚乙二醇(PEG)、聚酸酐、聚羟基脂肪酸酯(PHA)、聚对二氧环己酮、聚亚氨基碳酸酯、聚富马酸、上述材料的共聚物或混合 物,以及上述材料中的一种或多种与生物可降解的其它高分子材料的混合物。The biodegradable thrombus filter according to any one of claims 1 to 4, wherein the biodegradable polymer is selected from one or more of the group consisting of polylactic acid (PLA) and L-polylactic acid (PLLA). ), D-polylactic acid (PDLA), polyethylene glycol-polyglycolic acid (PGA), polycaprolactone (PCL), polyethylene glycol (PEG), polyanhydride, polyhydroxyalkanoate (PHA) , poly-p-dioxanone, polyiminocarbonate, polyfumaric acid, copolymer or mixture of the above materials And a mixture of one or more of the above materials with other biodegradable polymeric materials.
  6. 根据权利要求1至5中任一项所述的生物可降解血栓过滤器,其中,所述多孔管状支架体和/或多孔过滤网具有固定尺寸的孔隙、变化尺寸的孔隙或两者的结合。The biodegradable thrombus filter according to any one of claims 1 to 5, wherein the porous tubular stent body and/or the porous filter mesh has a fixed size pore, a variable size pore or a combination of the two.
  7. 根据权利要求1至6中任一项所述的生物可降解血栓过滤器,所述生物可降解血栓过滤器还包括缠绕在其上的金丝。The biodegradable thrombus filter according to any one of claims 1 to 6, further comprising a gold wire wound thereon.
  8. 根据权利要求1至7中任一项所述的生物可降解血栓过滤器,其中,所述血栓过滤器为腔静脉滤器。The biodegradable thrombus filter according to any one of claims 1 to 7, wherein the thrombus filter is a vena cava filter.
  9. 一种制备权利要求1至8中任一项所述的生物可降解血栓过滤器的方法,其中,所述方法使用四轴快速成型系统作为制造设备来进行,所述四轴快速成型系统包括:A method of producing the biodegradable thrombus filter of any one of claims 1 to 8, wherein the method is performed using a four-axis rapid prototyping system as a manufacturing apparatus, the four-axis rapid prototyping system comprising:
    (i)基座;(i) a pedestal;
    (ii)连接于所述基座的三轴X-Y-Z定位系统,其中所述X-Y-Z定位系统分别限定X、Y、Z方向;(ii) a three-axis X-Y-Z positioning system coupled to the base, wherein the X-Y-Z positioning system defines X, Y, and Z directions, respectively;
    (iii)安装在所述X-Y-Z定位系统上,并通过所述X-Y-Z定位系统移动的分配系统,所述分配系统含有一个挤出头;(iii) a dispensing system mounted on the X-Y-Z positioning system and moving by the X-Y-Z positioning system, the dispensing system comprising an extrusion head;
    (iv)连接于所述基座的第四轴系统,其包含在所述挤出头下方连接于所述基座的旋转杆,其中,所述旋转杆可以围绕其中轴作正向或反向转动;所述旋转杆的中轴平行于Y轴;以及(iv) a fourth shaft system coupled to the base, comprising a rotating rod coupled to the base below the extrusion head, wherein the rotating rod can be forward or reversed about the axis thereof Rotating; the central axis of the rotating rod is parallel to the Y axis;
    (v)计算机控制系统,其可以根据设定的程序精确地控制X-Y-Z定位系统从而精确地控制分配系统的挤出头在X、Y、Z方向上的运动,并且精确地控制第四轴系统的旋转杆围绕其中轴的转动;(v) a computer control system that can accurately control the XYZ positioning system according to a set program to accurately control the movement of the extrusion head of the dispensing system in the X, Y, Z directions, and precisely control the fourth axis system Rotation of the rotating rod about its axis;
    所述方法包括以下步骤:The method includes the following steps:
    1)根据所要制备的过滤器的外形、尺寸来制备实心或空心的模具;1) preparing a solid or hollow mold according to the shape and size of the filter to be prepared;
    2)采用计算机设计生物可降解聚合物纤维的沉积式样的程序;2) a program for designing a deposition pattern of biodegradable polymer fibers using a computer;
    3)将所述模具固定到所述四轴快速成型系统的第四轴系统的旋转杆的位置处,使其能够在计算机控制系统的控制下随第四轴旋转杆作正向或反向转动;并将生物可降解聚合物加入四轴快速成型系统的分配系统内;3) fixing the mold to the position of the rotating rod of the fourth shaft system of the four-axis rapid prototyping system, so that it can rotate in the forward or reverse direction with the fourth shaft rotating rod under the control of the computer control system And incorporating the biodegradable polymer into the dispensing system of the four-axis rapid prototyping system;
    4)按照步骤2)设计的程序通过计算机控制系统控制X-Y-Z定位系统和第四轴系统,使分配系统精确地按照预先设计的生物可降解聚合物纤维的沉积式样挤出生物可降解聚合物纤维,沉积在第四轴上可以旋转的模 具的特定位置或者直接沉积在旋转杆上,从而制备出具有特定尺寸和结构的滤器主体前体;4) According to the procedure designed in step 2), the XYZ positioning system and the fourth axis system are controlled by the computer control system, so that the distribution system accurately extrudes the biodegradable polymer fiber according to the pre-designed deposition pattern of the biodegradable polymer fiber. a mold that can be rotated on the fourth axis a specific position of the tool or deposited directly on the rotating rod to prepare a filter body precursor having a specific size and structure;
    5)将步骤4)制备的滤器主体前体从模具上取下来,并将其两端分别用生物可降解聚合物纤维串起来形成多孔过滤网的顶端,或者其中一个或两个多孔过滤网的顶端也可以是在四轴快速成型系统上直接成型的,将中心线的一端连接到一个多孔过滤网的顶端,中心线的另一端经过滤器内部延伸通过另一个多孔过滤网的顶端至过滤器的外部,所述中心线上设置有两个以上卡位,通过中心线和卡位实现过滤器的牵拉膨胀并且过滤器的膨开尺寸可调,从而得到具有所需外形的血栓过滤器。5) removing the filter body precursor prepared in the step 4) from the mold, and stringing the two ends thereof with biodegradable polymer fibers to form the top of the porous filter, or one or two of the porous filters. The tip can also be formed directly on a four-axis rapid prototyping system, with one end of the centerline connected to the top of a porous filter, and the other end of the centerline extending through the interior of the filter through the top of the other porous filter to the filter. Externally, the center line is provided with more than two card positions, the tension expansion of the filter is realized by the center line and the card position, and the expansion size of the filter is adjustable, thereby obtaining a thrombus filter having a desired shape.
  10. 根据权利要求9所述的方法,其中,步骤1)中所述模具的外形为圆筒形、圆球形、橄榄球形、灯笼形、离心管形、或不规则形状;优选所述模具采用3D打印技术或者数控机床加工方法制备;The method according to claim 9, wherein the shape of the mold in the step 1) is a cylindrical shape, a spherical shape, a football shape, a lantern shape, a centrifugal tube shape, or an irregular shape; preferably, the mold is 3D printed. Technical or CNC machine tool processing methods;
    优选地,步骤3)中使用夹具对模具进行固定,或者通过将空心的模具套在第四轴系统的旋转杆上进行固定;或者Preferably, in step 3), the mold is fixed by using a jig, or by fixing the hollow mold on the rotating rod of the fourth shaft system; or
    优选地,步骤3)中所述固定是用所述模具替代第四轴系统的旋转杆来接收聚合物,将其固定在第四轴系统上,并使其能够在计算机控制系统的控制下作正向或反向转动;Preferably, the fixing in step 3) is to replace the rotating rod of the fourth shaft system with the mold to receive the polymer, fix it on the fourth shaft system, and make it under the control of the computer control system. Rotate in the forward or reverse direction;
    优选地,所述方法还包括步骤6)将金丝缠绕在血栓过滤器上。Preferably, the method further comprises the step of 6) winding the gold wire around the thrombus filter.
  11. 根据权利要求1至8中任一项所述的生物可降解血栓过滤器在制备用于预防或治疗静脉血栓栓塞症的器械中的用途。Use of a biodegradable thrombus filter according to any one of claims 1 to 8 in the manufacture of a device for the prevention or treatment of venous thromboembolism.
  12. 一种用于输送权利要求1至8中任一项所述的血栓过滤器的输送装置,其包括:血管鞘套件,该血管鞘套件包括外鞘和推送鞘,所述外鞘的末端设置有接头,所述推送鞘的末端设置有封堵帽,所述推送鞘与外鞘的尺寸相匹配,从而能够插入所述外鞘内,其特征在于,所述输送装置还包括装载管、定位鞘和牵拉丝,其中:A delivery device for delivering the thrombus filter of any one of claims 1 to 8, comprising: a vascular sheath kit comprising an outer sheath and a push sheath, the outer sheath being provided with an end a connector, the end of the push sheath is provided with a sealing cap, and the pushing sheath is matched with the outer sheath so as to be insertable into the outer sheath, wherein the conveying device further comprises a loading tube and a positioning sheath And pulling the wire, where:
    所述装载管的一端被配置成能够插入并固定在所述外鞘的接头中,所述装载管被配置成装载未膨开状态的血栓过滤器,并且在装载管的一端插入并固定在外鞘的接头后能够使推送鞘插入其中,并能够使推送鞘推动其中装载的血栓过滤器进入外鞘并穿过外鞘进入体内;One end of the loading tube is configured to be insertable and fixable in a joint of the outer sheath, the loading tube being configured to load a thrombus filter in an unexpanded state, and inserted and fixed at an outer sheath at one end of the loading tube The connector can insert the push sheath therein and enable the push sheath to push the thrombus filter loaded therein into the outer sheath and through the outer sheath into the body;
    所述定位鞘包裹在所述装载管外部并且可以在所述装置管外部自由滑动,所述定位鞘在沿着其长度方向上设置有刻度或档位,所述刻度或档位被配置成能够确定所述装载管与所述定位鞘的相对位置,从而结合推送 鞘的推送程度在体外确定输送到体内的血栓过滤器的膨开尺寸;The positioning sheath is wrapped outside the loading tube and is free to slide outside the device tube, the positioning sheath being provided with a scale or gear along its length, the scale or gear being configured to enable Determining a relative position of the loading tube and the positioning sheath, thereby combining push The degree of pushing of the sheath determines the expanded size of the thrombus filter delivered to the body in vitro;
    所述牵拉丝被配置成在输送血栓过滤器的过程中连接所述血栓过滤器的中心线并穿过推送鞘内部在推送鞘末端由封堵帽固定,并且在所述血栓过滤器在体内达到需要的膨开尺寸后能够在体外断开上述连接。The pull wire is configured to connect the centerline of the thrombus filter during delivery of the thrombus filter and pass through the interior of the push sheath at the end of the push sheath by the closure cap, and in the thrombus filter body The above connection can be broken outside the body after reaching the desired swell size.
  13. 根据权利要求12所述的输送装置,其中,所述推送鞘由可推入部分和不可推入部分组成,所述可推入部分为推送鞘能够插入外鞘、装载管和定位鞘的部分,在所述可推入部分全部插入外鞘、装载管和定位鞘之后,所述不可推入部分抵住装载管和/或定位鞘;其中:The delivery device according to claim 12, wherein said push sheath is composed of a pushable portion and a non-pushable portion, said pushable portion being a portion of the push sheath that can be inserted into the outer sheath, the loading tube, and the positioning sheath, After the pushable portion is fully inserted into the outer sheath, the loading tube and the positioning sheath, the non-pushable portion abuts the loading tube and/or the positioning sheath; wherein:
    所述定位鞘的长度≤所述装载管插入接头后剩余的长度,The length of the positioning sheath ≤ the length remaining after the loading tube is inserted into the joint,
    所述推送鞘可推入部分的长度>所述外鞘的长度,和The pushing sheath can push the length of the portion > the length of the outer sheath, and
    所述装载管插入接头后剩余的长度<所述推送鞘可推入部分与外鞘的长度差<所述装载管插入接头后剩余的长度+所述定位鞘的长度。The length remaining after the loading tube is inserted into the joint < the length difference between the push sheath pushable portion and the outer sheath < the length remaining after the loading tube is inserted into the joint + the length of the positioning sheath.
  14. 根据权利要求12所述的输送装置,其中,所述装载管和定位鞘均为圆柱形管。The delivery device of claim 12, wherein the loading tube and the positioning sheath are both cylindrical tubes.
  15. 根据权利要求12所述的输送装置,其中,所述外鞘、推送鞘、装载管和/或定位鞘由包含聚四氟乙烯的材料制成。The delivery device of claim 12, wherein the outer sheath, the push sheath, the loading tube, and/or the positioning sheath are made of a material comprising polytetrafluoroethylene.
  16. 根据权利要求12所述的输送装置,其中,所述定位鞘上有刻度或档位的部分为透明的、半透明的或为镂空的,以便于观察所述装载管与所述定位鞘的相对位置。The delivery device of claim 12, wherein the portion of the positioning sheath having a scale or gear is transparent, translucent or hollowed out to facilitate viewing of the loading tube relative to the positioning sheath position.
  17. 一种血栓过滤系统,其包括权利要求1至8中任一项所述的生物可降解血栓过滤器和权利要求12至16中任一项所述的输送装置。 A thrombus filtration system comprising the biodegradable thrombus filter of any one of claims 1 to 8 and the delivery device of any one of claims 12 to 16.
PCT/CN2016/110385 2016-12-16 2016-12-16 Biodegradable thrombus filter, and manufacturing method, application, and delivery device thereof WO2018107466A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/CN2016/110385 WO2018107466A1 (en) 2016-12-16 2016-12-16 Biodegradable thrombus filter, and manufacturing method, application, and delivery device thereof
CN201680090403.7A CN109963527B (en) 2016-12-16 2016-12-16 Biodegradable thrombus filter, preparation method, application and conveying device thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2016/110385 WO2018107466A1 (en) 2016-12-16 2016-12-16 Biodegradable thrombus filter, and manufacturing method, application, and delivery device thereof

Publications (1)

Publication Number Publication Date
WO2018107466A1 true WO2018107466A1 (en) 2018-06-21

Family

ID=62557806

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2016/110385 WO2018107466A1 (en) 2016-12-16 2016-12-16 Biodegradable thrombus filter, and manufacturing method, application, and delivery device thereof

Country Status (2)

Country Link
CN (1) CN109963527B (en)
WO (1) WO2018107466A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109498207A (en) * 2018-12-12 2019-03-22 张辉 A kind of novel inferior caval vein filtration system and its intelligent withdrawal system
CN112155813A (en) * 2020-09-29 2021-01-01 北京华医圣杰科技有限公司 Ventricular volume reduction device
CN116919652A (en) * 2023-09-18 2023-10-24 北京心祐医疗科技有限公司 Degradable filter

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112022425A (en) * 2020-09-11 2020-12-04 复旦大学附属中山医院 Thrombus filter device

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6056993A (en) * 1997-05-30 2000-05-02 Schneider (Usa) Inc. Porous protheses and methods for making the same wherein the protheses are formed by spraying water soluble and water insoluble fibers onto a rotating mandrel
US20020138094A1 (en) * 1999-02-12 2002-09-26 Thomas Borillo Vascular filter system
US20070078481A1 (en) * 2005-10-04 2007-04-05 Cook Incorporated Embolic protection device
CN102149859A (en) * 2009-06-25 2011-08-10 三维生物科技有限公司 Methods and apparatus for fabricating porous three-dimensional tubular scaffolds
CN203885663U (en) * 2014-04-14 2014-10-22 高志康 Release system capable of degrading vena cava filter
CN104274867A (en) * 2014-03-10 2015-01-14 北京阿迈特医疗器械有限公司 Degradable polymer support as well as forming method and application thereof
CN105120798A (en) * 2012-11-27 2015-12-02 康特戈医疗有限责任公司 Percutaneous transluminal angioplasty device with integral embolic filter
CN106175978A (en) * 2016-08-01 2016-12-07 罗中华 Guide gip filter

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241746B1 (en) * 1998-06-29 2001-06-05 Cordis Corporation Vascular filter convertible to a stent and method
WO2001060442A1 (en) * 2000-02-18 2001-08-23 The Foundry Llc Filtering devices and methods for filtering flow through a body structure
US20050021075A1 (en) * 2002-12-30 2005-01-27 Bonnette Michael J. Guidewire having deployable sheathless protective filter
US6773448B2 (en) * 2002-03-08 2004-08-10 Ev3 Inc. Distal protection devices having controllable wire motion
CN101147705A (en) * 2006-09-18 2008-03-26 深圳市先健科技股份有限公司 Controllable released biological ceramic thrombus filter and manufacturing method thereof
CN101491465A (en) * 2008-01-21 2009-07-29 微创医疗器械(上海)有限公司 Blood vessel filter
JP4510125B1 (en) * 2009-02-20 2010-07-21 株式会社ウィルファイン Intravascular thrombus trap
CN102085396A (en) * 2009-12-02 2011-06-08 复旦大学附属肿瘤医院 Medicine-carrying biodegradable vena cava filter and preparation method thereof
CN201551415U (en) * 2009-12-24 2010-08-18 中国人民解放军总医院 Degradable vena cava filter
CN202908879U (en) * 2012-11-30 2013-05-01 张福先 Biodegradable postcava filter
CN205198208U (en) * 2015-10-15 2016-05-04 先健科技(深圳)有限公司 Filter
CN105963048A (en) * 2016-06-15 2016-09-28 江门市众新思创医疗科技有限公司 Degradable vena caval filter

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6056993A (en) * 1997-05-30 2000-05-02 Schneider (Usa) Inc. Porous protheses and methods for making the same wherein the protheses are formed by spraying water soluble and water insoluble fibers onto a rotating mandrel
US20020138094A1 (en) * 1999-02-12 2002-09-26 Thomas Borillo Vascular filter system
US20070078481A1 (en) * 2005-10-04 2007-04-05 Cook Incorporated Embolic protection device
CN102149859A (en) * 2009-06-25 2011-08-10 三维生物科技有限公司 Methods and apparatus for fabricating porous three-dimensional tubular scaffolds
CN105120798A (en) * 2012-11-27 2015-12-02 康特戈医疗有限责任公司 Percutaneous transluminal angioplasty device with integral embolic filter
CN104274867A (en) * 2014-03-10 2015-01-14 北京阿迈特医疗器械有限公司 Degradable polymer support as well as forming method and application thereof
CN203885663U (en) * 2014-04-14 2014-10-22 高志康 Release system capable of degrading vena cava filter
CN106175978A (en) * 2016-08-01 2016-12-07 罗中华 Guide gip filter

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109498207A (en) * 2018-12-12 2019-03-22 张辉 A kind of novel inferior caval vein filtration system and its intelligent withdrawal system
CN109498207B (en) * 2018-12-12 2023-09-19 中国人民解放军陆军军医大学第一附属医院 Inferior vena cava filtering system and intelligent recovery system thereof
CN112155813A (en) * 2020-09-29 2021-01-01 北京华医圣杰科技有限公司 Ventricular volume reduction device
CN112155813B (en) * 2020-09-29 2024-04-23 北京华医圣杰科技有限公司 Ventricular volume-reducing device
CN116919652A (en) * 2023-09-18 2023-10-24 北京心祐医疗科技有限公司 Degradable filter
CN116919652B (en) * 2023-09-18 2024-01-19 北京心祐医疗科技有限公司 Degradable filter

Also Published As

Publication number Publication date
CN109963527B (en) 2021-12-24
CN109963527A (en) 2019-07-02

Similar Documents

Publication Publication Date Title
US8388676B2 (en) Disintegrating stent and method of making same
US20210228224A1 (en) Thrombectomy devices and methods
US20210393271A1 (en) Devices and methods for excluding the left atrial appendage
CN108433769B (en) Occlusion device
US11426172B2 (en) Devices and methods for excluding the left atrial appendage
CN105228688B (en) Vascular treatment device and method
WO2018107466A1 (en) Biodegradable thrombus filter, and manufacturing method, application, and delivery device thereof
CN107496051B (en) Coated medical device and production and preparation method thereof
US5725552A (en) Percutaneous catheter directed intravascular occlusion devices
US6949103B2 (en) Method and device for filtering body fluid
US8721679B2 (en) Apparatus and method for closing an opening in a blood vessel using a permanent implant
US20070055365A1 (en) Stent with integrated filter
US20140330304A1 (en) Neuroaneurysm occlusion and delivery device and method of using same
JP7366933B2 (en) Devices and methods for eliminating the left atrial appendage
JP2004508879A (en) Apparatus for implanting a device in the atrial appendage
JP6899832B2 (en) Devices and methods for eliminating the left atrial appendage
CN111658056B (en) Embolism particle for medical use and preparation method thereof
CN105828847B (en) Production of absorbable polymer tubes from yarn
JP2019505347A (en) Fiber tube for stenting
CN115670737A (en) Multistage thrombus filter equipment of repeatedly fixing a position
WO2023087475A1 (en) Thrombectomy device
US20230030299A1 (en) Covered vascular plug
WO2018138260A1 (en) Production of resorbable polymer tubes from multi-component filaments

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16923755

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 10.10.2019).

122 Ep: pct application non-entry in european phase

Ref document number: 16923755

Country of ref document: EP

Kind code of ref document: A1